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THE ROLE OF STEM CELLS IN ADIPOSE TISSUE REMODELING 
Candice ReShay Holden 
November 25, 2014 
 The work presented in this dissertation outlines the role of stem cells in 
the remodeling of adipose tissue under conditions of nutrient excess. Obesity-
induced variations in adipose tissue stem cell distribution were uncovered by 
analysis of the stromal vascular fraction isolated from mice fed a high fat diet for 
several weeks. Bone marrow cell transplantation was used to determine the 
derivation of progenitor cells found in adipose tissue; and supplementation of 
depleted progenitor cell populations achieved via direct cell transplantation, 
helped to determine the contribution of these progenitor cells to the remodeling 
process.  
 The dissertation is presented in five chapters outlining the adipose tissue 
remodeling process, metabolic changes which occur in adipose tissue in 
response to nutrient excess, diet-induced variations in adipose tissue stem cell 
distribution, and the impact of stem cell transplantation on remodeling of adipose 
tissue. Chapter one serves as a general introduction defining the development of 
obesity, health implications of obesity and methods by which adipose tissue can 
remodel in response to nutrient excess. Chapter two describes the metabolic 




diet. The third chapter details changes in adipose tissue stem cell distribution in 
response to nutrient excess. The studies presented in chapter three suggest that 
obesity is associated with an imbalance in adipocyte and endothelial progenitor 
cells. This imbalance was corrected to determine if doing so was sufficient to 
ameliorate obesity-associated complications and data from these studies are 
presented in chapter four. Finally, a comprehensive discussion of the implications 
of these studies is outlined in chapter five.     
 Chapters two and three focus on the impact of high fat diet on the 
metabolic profile of adipose tissue and distribution of adipose tissue stem cells. 
Chapter four centers on correcting the progenitor cell ratio, skewed by 
consumption of high fat diet. The studies presented in the fourth chapter suggest 
increasing the endothelial progenitor cell population promotes cell engraftment 
into vasculature of the adipose tissue. Increasing the capacity of these cells 
further supports vessel formation and engraftment in obese tissue and may 
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Obesity epidemic in the United States 
Climbing rate of obesity   
The prevalence of obesity in the United States has increased remarkably 
over the past four decades (1, 2). The National Health and Nutrition Examination 
Survey reported the prevalence of obesity in the United States as 15% from 1976 
to 1980 (1). Between the years of 1988 and 1994, the Centers for Disease 
Control (CDC) reported that the prevalence of obesity was approximately 22.9%. 
By the year 2000, the prevalence of obesity was reported to be 30.5% and, in 
2010, that statistic increased again to 35.7% (3-6). It was recently reported that, 
in the United States, 34.9% of individuals over the age of 20 are currently obese 
(7). In the state of Kentucky, 31.3% of the population is considered obese (4). 
The high prevalence of obesity is important because it increases the incidence of 
pre-diabetic and diabetic states and is associated with numerous co-morbidities. 
As such, a substantial financial burden, due to obesity, has been imparted on the 
economy of the United States. Most recent estimates suggest that $147 billion 
US dollars are spent on the treatment of obesity with obese individuals paying an 
additional $1,429 each year for medical treatment (8)! 
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Potential causes for this relatively recent increase in obesity prevalence 
are low levels of physical activity and increased caloric intake. The CDC reports 
that only 48% of adults meet the guidelines for physical activity, i.e., 30 minutes 
of moderate activity or endurance training 5 days per week or 20 minutes of 
vigorous activity 3 days per week (9, 10).  In Kentucky, where the obesity 
prevalence is above 30%, only 17.7% of the state’s surveyed population were in 
compliance with the CDC’s physical activity recommendations in 2000 (4, 11). In 
2003-2004, the CDC sampled 1,714 adults and reported that only 3% of non-
sleeping time was spent exercising, 58% of the day was spent in sedentary 
behavior and 39% was spent engaging in a light-intensity activity (12).  
Hyperphagia and consumption of a diet rich in fat, are also known to 
contribute to the development of obesity (13-15), and, expectedly, physical 
inactivity combined with the consumption of excess nutrients exacerbates the 
obese condition (11). Excess lipids are deposited in peripheral organs and this 
ectopic deposition of fat has been implicated in the development of several 
chronic disease states (16). Ectopic fat deposition in organs such as the skeletal 
muscle, pancreas, and liver has been shown to result in glucose intolerance, 
hyperinsulinemia, and hyperlipidemia (16, 17).  Though diet-induced obesity is 
the predominant focus of our work, there is also a wealth of evidence to suggest 
that genetic makeup could also play a role in the determination of body 
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Definition and Diagnosis of obesity 
Obesity develops as caloric intake consistently exceeds energy 
expenditure generating a surplus of nutrients which are not used for biological 
processes and are stored as esterified fat. This condition has been classically 
defined as having a body mass index (BMI) > 30. With the rate of obesity steadily 
rising, in November of 2013, the American Medical Association suggested that 
obesity should be acknowledged as a disease and should be treated as such. 
This would include physicians advising patients to utilize weight loss programs as 
a means to avoid obesity-related complications and to improve and potentially 
alleviate any pre-existing conditions related to increased adiposity (22).  
BMI is calculated using body weight and height (Scheme 1). It provides an 
estimate of the body fat content of an individual. Using a BMI measurement as 
the sole method for quantification of body fat content could lead to an inaccurate 
estimation for exceptionally tall individuals over 7 feet in height, those with 
decreased muscle mass such as the elderly, those with increased muscle mass 
such as athletes, and pregnant woman. To more accurately assess body fat, 
multiple measurements should be made. 
There are several ways to measure body fat, including measurement of 
waist circumference, skin calipers, bioelectrical impedance, and Dual-energy X-
ray Absorptiometry or Dexascan. Measurements of waist circumference and 
bioelectrical impedance are relatively simple to obtain. According to the National 
Institutes of Health (NIH), women with a waist circumference > 35 inches or men 
measuring > 40 inches show increased risk for obesity-related diseases. 
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Bioelectrical impedance utilizes gentle electrical impulses and the difference in 
conductivity of fat and muscle to discriminate between lean mass and fat mass. 
Calipers can be used be used to measure body fat. For this, the skin is pinched 
in several locations and the thickness of the skin flap is measured. Calipers can 
be used on the arm, abdominal region, thighs, and several other locations. The 
measurements from each of these regions along with the individual’s age can 
then be used in an algorithm to calculate body fat. This algorithm utilizes the 
Jackson-Pollack and Siri equations as described in Scheme 1 (23-25). Tools to 
complete all of these assessments are readily available.  
Dexascan, the most accurate and costly of the techniques presented here, 
takes very little time to complete and is painless to the subject, however it cannot 
be measured at home. For this, the subject undergoes a fairly standard X-ray 
procedure and the bone, fat, and lean mass can be calculated based upon the 
absorption of x-rays in each tissue type (26). 
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Scheme 1. Calculation of body mass index and body fat percentage using 
skin calipers.  The equation for the calculation requires a measurement of total 
body weight and height as outlined above, (A). Total body density is first 
calculated using the Jackson-Pollack equation which is gender specific. The Siri 
equation, which can be applied to both males and females, is then used to 
determine the body fat percentage, (B).  
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Function and types of adipose tissue  
It has been suggested that adipose tissue is a major regulator of metabolic 
homeostasis.  This is partly via its chief function, which is to esterify free fatty 
acids (FFA) and store excess lipids as triglycerides to serve as a reserve energy 
source (16). The ability to compile a nutrient reserve from excess caloric intake is 
conserved across several species (21, 27, 28). In humans, fat is stored in 
visceral and subcutaneous white adipose tissue depots which are located in 
several areas of the body. Visceral depots are most often found in the abdominal 
region, surrounding the intestines and kidneys. Subcutaneous depots are located 
just beneath the skin and pads in the abdominal area, buttocks, and thighs are 
most substantially expanded due to nutrient overload. Distribution of fat changes 
with age, typically increasing more in the visceral abdominal region (27). Insulin 
resistance occurs when fat can no longer be accommodated by these depots and 
begins to accumulate in non-adipose organs such as skeletal muscle, liver, 
kidneys, and the heart (16). 
Though white adipose tissue is the most abundant fat source in adults, 
brown and beige adipose tissues also function to maintain metabolic stability. 
Brown fat is also believed to originate from the mesoderm and is a highly active 
tissue (27). The primary function of brown adipose tissue is thermogenesis. In 
newborns there is an increased amount of brown fat that is significantly 
decreased with age. This tissue helps to maintain basal body temperature and 
can be stimulated to increase energy expenditure  and produce heat in times of 
need with the support of uncoupling protein-1 (UCP-1) located in the 
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mitochondrial membrane (29). In conditions where brown adipose tissue is not 
present, diet-induced obesity, diabetes, and hyperlipidemia have been observed 
(30).  
White adipose tissue has been shown to dedifferentiate and change to a 
more “brown-like” phenotype due to extended exposure to cold or increased 
sympathetic stimulation (27, 31-33). UCP-1 positive cells appear to be dispersed 
throughout white adipose depots. More recently, these cells have been called 
“beige” adipocytes. These cells have a lineage consistent with that of white 
adipocytes but express UCP-1 and generate heat upon stimulation (17, 23-26). 
UCP-1 expression has also been observed to increase with the use of 
thiazolidinediones (TZDs) (34). 
Adipose tissue composition and progenitor identification  
Adipose tissue is composed of a multitude of cells, the functional cell type 
being adipocytes. Mature or terminally differentiated adipocytes can easily be 
identified by immunohistological staining for the protein perilipin. Perilipin is found 
in the thin cell membrane of the adipocyte. Oil Red-O and Nile red dyes can be 
used to identify lipid droplets within the mature adipocytes. In white adipose 
tissue, these droplets are large and unilocular, unlike those of brown adipose 
tissue which are multilocular in nature. As previously described, brown 
adipocytes express UCP-1 whereas white adipocytes are leptin positive.  Both 
white and brown mature adipocytes express Peroxisome Proliferator- Activated 
Receptor gamma 2 (PPARƔ2), Glucose Transporter Type 4 (GLUT4), fatty acid 
synthase, and are regulated by insulin (27, 35). 
 
 9  
 
 When adipose tissue is digested using collagenase to isolate specific cell 
types of interest, lipid-loaded adipocytes float due to decreased density. The 
mixture of cells which can be pelleted is referred to as the stromal vascular 
fraction (SVF). The SVF contains mesenchymal stem cells including 
preadipocytes, vascular/endothelial progenitor cells, pericytes, dendritic cells, 
fibroblasts, mature endothelial cells, immune cells such as macrophages, T cells, 
B cells, and monocytes as well as a host of other cell types (36). Preadipocytes 
or adipocyte progenitor cells can be distinguished by the expression of CD29, 
CD24, CD34, and stem cell antigen-1 (Sca-1).  
 In 2008, Rodeheffer, et al. showed that progenitor cells were sorted from 
the SVF based upon their expression profile of cell surface antigens for CD24, 
CD29, CD34, CD31, Sca-1 and lineage marker (Lin). Four cell types were 
isolated and cultured for in vitro analysis. Cultures enriched for cells positive for 
CD29, CD34, and CD24 and negative for CD31 and the lineage marker (Lin) 
showed a significant increase in Oil Red-O staining compared to unfractionated 
SVF. However, when expression levels of adipsin and aP2 were quantified, cells 
which were positive for CD24 in addition to CD29, CD34, and Sca-1 and negative 
for CD31 and the lineage marker (Lin) had the highest levels of expression for 
both adipocyte markers. When CD24, CD29, CD34, Sca-1 positive and CD31 
and Lin negative cells were transplanted into insulin resistant A-Zip mice lacking 
functional epididymal white adipose tissue, the cells were able to proliferate and 
form a functional fad pad similar in size to that of a normal, wild-type mouse just 
12 weeks after injection of 50, 000 cells. Systemically, plasma insulin and 
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glucose levels decreased to the level of the wild-type and adiponectin levels were 
increased. The cells were harvested from mice expressing green fluorescent 
protein (GFP) and after completion of the study, the fat pads harvested from the 
transplanted A-Zip mice were identified as GFP positive, unilocular, lipid-loaded 
cells (37).  
Adipose tissue deficiency: Lipodystrophies 
 Although more than one-third of the US population struggles with obesity, 
a smaller amount of Americans, less than 200,000 people, have the opposite 
problem and are unable to store fat properly. This is a rare condition described 
by the NIH-Office of Rare Diseases as lipodystrophy. This disease can be 
attributed to a marked decrease in leptin, utilization of certain drug therapies 
such as antiretroviral drugs which are commonly used for the treatment of HIV, or 
genetic predisposition (38).  
Several types of lipodystrophy can be attributed to genetics (39, 40). 
Mutations in genes encoding for PPARƔ, AGPAT2, AKT2, CAV1, PTRF, CIDEC, 
lamin A/C, ZMPSTE24, and BSCL2 are some of the causes for the development 
lipodystrophy. These mutations can cause problems in the development, 
differentiation, or lead to the premature death of adipocytes. Due to the inability 
to properly store fat, individuals with lipodystrophy are predisposed to diabetes, 
pancreatitis, end stage renal disease, diabetic retinopathy, CHD, renal failure, 
and even arrhythmias which could induce sudden death. Currently, the only 
approved treatments for individuals with this disease work to decrease excess 
visceral adiposity. There is not much that is currently offered to alter fat storage 
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in lipodystrophy individuals, such a treatment might create a more favorable, less 
pathogenic distribution of fat (40).  
 
Health implications and consequences of obesity 
Insufficient amount of physical activity and increased in caloric intake are 
major contributors to the rise of obesity in American adults. The development of 
obesity is associated with several complications. Obesity- associated 
complications include, but are not limited to: insulin resistance, Type 2 Diabetes 
(T2D), predisposition for certain cancers, hypertension, dyslipidemia, metabolic 
syndrome, stroke, and coronary heart disease (10, 41-46).  
Coronary heart disease (CHD) is defined as the development of plaques 
in coronary arteries which may impede blood flow as they become larger over 
time. This decrease in blood supply could lead to angina, heart attack and 
arrhythmias.    There is evidence that increasing aerobic activity beyond the 
amount specified in guidelines set by the American Heart Association (AHA) and 
American College of Sports Medicine has potential health benefits and can 
reduce the risk for CHD (10). The National Runners’ Health Study provided 
information from a cohort of 8,283 runners in which the amount of self-reported 
weekly physical activity was strongly correlated with biomarkers of physical 
activity such as increased high-density lipoprotein (HDL), reduction of 
hypertension, lower blood pressure, decreased adiposity, lower triglyceride level, 
and decrease CHD risk (41). After 10 years, a follow-up survey was administered 
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to the group inquiring about the need for or completion of coronary artery bypass 
surgery and percutaneous transluminal coronary angioplasty as well as 
information about the number of heart attack and angina diagnoses experienced 
by the study participants. This assessment revealed the correlation of running 
and the reduction of CHD risk could be mediated by the baseline BMI of the 
individual, suggesting that running may be of greater benefit to individuals with a 
higher BMI than those with a lower BMI at baseline. However, higher baseline 
BMI significantly increased the risk for the development of CHD, hypertension, 
high cholesterol, and diabetes; even in those that engaged in vigorous physical 
actively on a regular basis (10). 
There have been numerous studies implicating obesity as a confounding 
factor for the development of Type 2 Diabetes (T2D) and insulin resistance (42-
46). The underlying cause being adipocyte dysfunction and increased caloric 
intake for both T2D and insulin resistance offers support for the association 
between the conditions and the development of obesity. It has also been 
established that adipose tissue is a major regulator of systemic glucose and lipid 
homeostasis. 
Obesity can induce both changes in metabolism within adipocytes 
themselves and more broad changes in the adipose tissue as whole. Diet 
induced-obesity has been shown to cause a decline in mitochondrial abundance 
in white adipocytes over time (47-50). This phenomenon has been described as 
adipose tissue “whitening” (15, 51, 52). The dynamic nature of adipose tissue 
allows adipocytes to change phenotype along a continuum with highly 
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metabolically active brown adipocytes at one end and white adipocytes with 
decreased metabolic activity at the other (15, 53). Metabolic changes that occur 
during the whitening process have not been completely described; however, our 
metabolomic analyses have revealed that diet-induced metabolic changes 
precede adipose tissue inflammation and loss of mitochondria in visceral adipose 
tissue. These changes appear to coincide with perturbations of lipid, amino acid, 
glucose, and energy metabolism, posing a threat to systemic metabolic 
homeostasis (15).  
As previous stated, consumption of HF diet can also cause dysfunction in 
adipose tissue as a whole. Under conditions of nutrient excess, some adipocytes 
expand to sizes as large as 10,000µm² (54). Such expansion requires extreme 
remodeling of the adipose tissue microenvironment. Adipocyte expansion at that 
level can lead to hypoxia due to the inability of oxygen to diffuse such a great 
distance from the capillary and cell necrosis once the adipocytes hypertrophy 
pass the point of sustainability (55-58). Hypertrophied adipocytes can secrete a 
host of pro-inflammatory cytokines and chemokines including macrophage 
chemoattractant protein (MCP-1). This results in the recruitment of inflammatory 
cells to clear dead cells (58, 59). Influx of inflammatory cells like macrophages 
and T cells, creates a state of low-grade chronic inflammation. Tumor necrosis 
factor-α (TNFα) is also increased in inflamed adipose tissue spurring more 
recruitment of inflammatory cells and disrupting the lipid storage process leading 
to insulin resistance. Together, these events are indicative of unfavorable, 
pathological adipose tissue remodeling (42, 56, 60, 61). 
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Metabolically favorable adipose tissue remodeling  
A major remodeling of the adipose tissue is believed to occur after 
resolution of the necrosis-induced inflammatory response associated with 
excessive adipocyte hypertrophy. This phenomenon has been coined the 
“necrotic wave”. After resolution of inflammation, progenitor cells in the adipose 
tissue proliferate, differentiate, and repopulate the organ. This is associated with 
restoration of insulin sensitivity and is known as favorable adipose tissue 
remodeling (56).   
Increased storage capacity of the white adipose tissue depots appears to 
be beneficial to systemic metabolism. An increase in fat storage capacity 
decreases ectopic storage of excess lipids in peripheral organs, which appears to 
prevent insulin resistance. One such example, was reported by Dr. Philipp 
Scherer’s group. They studied transgenic mice overexpressing adiponectin. The 
mice presented a phenotype of healthy, morbid obesity. The group proposed that 
the increase in adiponectin served as somewhat of a starvation signal, prompting 
the body to store esterified fat in the adipose tissue as opposed to peripheral 
organs. In so doing, there was no substantial ectopic deposition of fat which 
allowed for the preservation of insulin sensitivity and metabolic homeostasis in 
the transgenic mice (41). 
Likewise, obese (ob/ob) mice expressing a mitochondrial membrane 
protein called MitoNEET have the capacity to store enormous amounts of fat 
while still maintaining systemic insulin senstivity and preventing adipose tissue 
inflammation. MitoNEET exists in the outer mitochondrial membrane and 
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functions to increase the overall activity of the mitochondria, stimulate 
adiponectin production, and decrease damage due to reactive oxygen species. 
Mice overexpressing this gene can therefore store a tremendous amount of lipid 
in their white adipose tissue depots (62).  In both cases, the mice become 
morbidly obese with body weights as high as 130 grams, yet metabolic 
homeostasis was not disturbed.  
In both metabolically normal, obese transgenic mouse models, the 
adipose tissue consists of numerous small adipocytes which have been shown to 
derive from adipocyte precursor cells (37, 62, 63). The presence of smaller 
adipocytes have been shown to correlate with increased lipid storage capacity 
and increased mitochondrial density promoting metabolically favorable adipose 
tissue remodeling (64). Perhaps availability of adipocyte precursors with 
increased proliferative and differentiation capacity could be important in 
promoting favorable metabolic remodeling under conditions of nutrient excess.  
 
Adipose tissue stem cells  
Origin and regulation   
Fat is believed to have originated from the mesoderm in humans, similar 
to bone and muscle tissues. Mesenchymal stem cells (MSCs), found in bone 
marrow, also have mesodermal lineage and upon differentiation, these cells have 
the capacity to differentiate into adipocytes, osteoblasts, chondrocytes, 
myoblasts, and connective tissue (27). Cells that give rise to mature adipocytes 
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are known as preadipocytes or adipocyte progenitor cells. Though the specific 
number of steps in the differentiation process of a MSC to a mature adipocyte is 
unclear, Spiegelman and Rosen propose that there are four distinct stages in the 
maturation process of murine preadipocytes. These stages are growth arrest, 
clonal expansion, early differentiation, and terminal differentiation (65). Each of 
these steps can be transcriptional regulated impacting differentiation and 
maturation of the adipocyte. Major contributors to these processes are PPARƔ 
and C/EBP.  
As previously discussed, mesenchymal stem cells expressing CD24, 
CD29, CD34, and Sca-1 can give rise to mature adipocytes in vivo, but these 
cells have been shown to lose expression of CD24 after commitment to the 
adipocyte lineage. It was reported that 4 days after transplantation of CD24 
positive preadipocytes into A-Zip mice, 91.4% of the transplanted cells were 
negative for CD24 after analysis by flow cytometry (37, 66). This could prove to 
be an issue in tracking these newly modified cells. Interestingly, the CD24 
negative cells showed increased expression levels of adipocyte markers like 
PPARƔ and C/EBPα.  
PPARƔ has been shown to have the most profound effect on adipocyte 
differentiation. Without adequate expression of the transcription factor, cells will 
not terminally differentiate and in some cases, may even dedifferentiate, resulting 
in lipid unloading and a decline in adipocyte marker expression. There are two 
PPARƔ isoforms, PPARƔ1 and PPARƔ2. PPARƔ2 is an accepted adipocyte-
specific marker, though in cases when PPARƔ2 is unavailable, PPARƔ1 has 
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been shown to be unregulated in an attempt to maintain metabolic homeostasis. 
In mice without the gene for PPARƔ2, adipogenesis is decreased as well as 
insulin sensitivity (27, 35). C/EBP is a family of transcription factors including 
CHOP, C/EBPα, C/EBPβ, C/EBPδ, and C/EBPƔ; C/EBPα having the most 
profound impact on adipogenesis in white adipose tissue (27). Without C/EBPα, 
mice developed hypertrophied brown adipocytes and were unable to form mature 
white adipose tissue in both subcutaneous and visceral depots (67).  
Specific cells of interest  
 Our work has been focused on the role of adipose progenitor and 
endothelial progenitor cells. Both cell types have been shown to have 
regenerative capacity, improving peripheral blood flow (68, 69) and repopulating 
the adipose tissue during the remodeling process (56). As previously stated, 
mesenchymal stem cells of the adipose tissue commit to the adipocyte lineage 
and are then named adipocyte progenitors or preadipocytes. The commitment of 
these cells is transcriptionally regulated in large part by PPARƔ. Once the cells 
have committed, adipogenesis commences and the cells begin to take up lipid. 
The lipid-loaded cells are then considered to be mature adipocytes (70).  
Endothelial progenitor cells (EPCs) have been shown to integrate into 
existing vasculature and improve blood flow. These cells are recruited to sites of 
vascular injury to help repair damage. Levels of these cells can be influenced not 
only by obesity, but by several environmental factors such as exposure to air 
pollution and components of cigarette smoke (68, 69, 71, 72). Reduced EPC 
count has been correlated with increased risk of cardiovascular disease and 
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decreased ability to create functional vascular networks, thus these cells are of 
particular interest to our group (73-78). The cells were first characterized by a 
group at Tuft’s University lead by Takayuki Asahara. In 1997, this work was 
published in Science and is now considered to be a seminal paper in the field of 
vascular biology. The paper asserts that progenitor cells in blood have the 
capacity to improve vascularity in ischemic tissues. These cells have been shown 
to differentiate into mature endothelial cells in vivo and integrate into damaged 
vascular beds or organize to form new capillary networks. CD34+ cells isolated 
from human blood and Flk1+ cells isolated from mouse blood were transplanted 
into a mouse or rabbit model of hindlimb ischemia 2 days after removal of the 
femoral artery.  CD34+ cells integrated into damaged capillary networks and 
generated new capillary beds in the ischemic limb within 6 weeks of 
transplantation. Flk+ cells were also observed in capillaries and small arteries in 
the ischemic limb 4 weeks after transplantation. This integration was not 
observed in non-ischemic limbs suggesting EPCs promote vascularity in 
ischemic tissue. All of the transplanted cells which engrafted into the ischemic 
tissues stained positive for CD31, a marker of mature endothelial cells, 
corroborating the group’s hypothesis that EPCs differentiate into mature 
endothelium in vivo  (79).  
Since the initial identification of EPCs, several studies have confirmed that 
progenitors similar to Asahara’s, CD34+ or Flk+ cells have regenerative capacity 
(68, 69, 71, 80-82). Taken together, it can be concluded that EPCs function to 
repair damaged vasculature in order to maintain adequate tissue oxygenation, 
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preventing further ischemia-induced cell death and fibrosis (75). Interestingly, the 
term “EPC” is a general one describing a variety of cell types that have been 
shown to promote angiogenesis or vessel repair (68, 69, 71, 75, 80, 82). We 
chose to investigate the role of Flk1 and Sca-1 positive cells which have been 
affirmed as an EPC population in mice (68, 69, 71).  We hypothesize that both 
adipocyte and endothelial progenitor cell populations are crucial for the favorable 
remodeling of adipose tissue during obesity, ameliorating hypoxia and promoting 
adipocyte turnover.  
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Project Objective  
Obesity is one of most rapidly growing health crises in the United States 
and its prevalence is on the rise worldwide. Increased risk for the development of 
Type 2 diabetes, insulin resistance, and cardiovascular disease are just three of 
the most devastating complications associated with obesity.  Achieving a more 
complete understanding of the mechanisms that regulate adiposity could 
facilitate the development of new treatment strategies for controlling obesity and 
the associated cardiovascular complications.  Environmental and genetic factors 
can contribute to adipose tissue distribution and increased adiposity, but studies 
investigating a form of “healthy,” morbid obesity could provide insight into the 
mechanism by which lipid storage can be stimulated under conditions of nutrient 
excess while maintaining metabolic homeostasis, preventing diet-induced insulin 
resistance.  Small adipocytes, lack of adipose tissue inflammation, and adequate 
adipose tissue oxygenation are hallmarks of this favorable remodeling process, 
which is in stark contrast to typical unfavorable, diet-induced pathological 
adipose tissue remodeling, characterized by large adipocytes, adipose tissue 
hypoxia, chronic inflammation, and systemic insulin resistance. We are interested 
in determining why the pathological form of adipose remodeling is generally the 
default for lipid storage.  We hypothesize that obesity impairs stem cell-
mediated adipose tissue remodeling.   
Although obesity is a disease relating to metabolism in general, little is 
known about the metabolic changes occurring in adipose tissue during the 
course of obesity.  This is important because of the likely metabolic 
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underpinnings of pathological and metabolically favorable adipose tissue 
remodeling. Thus, in Chapter 2, we examine the metabolic changes that occur in 
the visceral adipose tissue with obesity. Importantly, this involves obesity model 
characterization and in-depth assessment of the metabolic pathways that change 
in pathological forms of adipose remodeling. To determine how obesity regulates 
stem cell populations in adipose tissue, we assessed changes in stromal adipose 
stem cell populations in visceral and subcutaneous adipose tissue of adult 
C57BL/6J mice fed a low- or high-fat diet (Chapter 2). To completely address 
Aim 1, we also measured proliferation of adipose tissue stem cells in obese and 
lean mice, and examined how reversion to a low-fat diet affects adipose tissue 
stromal cell population in mice. The results from these studies will be discussed 
in Chapter 3. Our data suggest that conditions of obesity result in a significant 
decline in the availability of endothelial progenitor cells in the adipose tissue. To 
delineate the contribution of stem cells to adipose tissue remodeling, isolated 
endothelial progenitor cells were also transplanted directly into the visceral 
adipose tissue to determine if supplementation of these vascular progenitors was 
sufficient to promote a positive form of adipose tissue remodeling (Chapter 4, 
Aim 2). Since we also saw a decrease in endothelial nitric oxide synthase with 
increased adiposity (54), bone marrow cells were isolated from mice 
overexpressing endothelial nitric oxide synthase and transplanted into wild-type 
mice which were then placed on high-fat diet for several weeks. The hypothesis 
being that simultaneously increasing endothelial nitric oxide synthase and stem 
cells availability in the adipose tissue may be sufficient to promote physiological 
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adipose tissue remodeling. Changes in body weight, insulin sensitivity, 
inflammation, adipocyte hypertrophy, were measured. The results of these 
studies will help in assessing the impact of obesity and inflammation on the 
competency of adipose tissue stem cells and in evaluating whether cell therapy 















METABOLIC REMODELING OF WHITE ADIPOSE TISSUE IN OBESITY 
 
Introduction  
The increasing prevalence of obesity is a principal health concern 
worldwide. In 2008, approximately 1.5 billion adults aged 20 years or older were 
overweight, and 10% were obese (83). In the US, more than one-third of the 
adult population is currently obese (BMI >30), and 68% have a BMI>25 (84). By 
the year 2025, these numbers are expected to increase by more than 50% (85).  
These statistics are a cause for alarm. Obesity is  a powerful predictor of insulin 
resistance (86) and a major risk factor for several common medical conditions, 
such as type 2 diabetes (T2D), cardiovascular disease, non-alcoholic fatty liver 
and gallstones, Alzheimer’s disease, and cancers such as breast, colon, 
endometrial, and esophageal cancer (87).  
While lack of exercise is an undeniable risk factor for weight gain (87-89), 
excessive caloric intake appears to be one of the key factors fueling the obesity 
epidemic. In the past three decades, the average consumption of calories in the 
US has increased by at least 200 kcal/d per person, which could be partly 
attributable to an increase in the intake of energy-dense foods (90-93). Such 
poor dietary habits negatively affect metabolic homeostasis, which could not only 
promote obesity, but hasten the development of obesity-related co-morbidities as 
 
 24  
 
well.  Despite the simplicity of the apparent remedy (i.e., decreasing caloric 
intake), treatment of obesity remains a challenging crisis facing the health care 
system. The efficacy of losing weight via caloric restriction is limited by multiple 
challenges. These include an evolutionarily engendered guard against starvation 
and low fat mass (85, 94) and a propensity to increase caloric efficiency during 
dieting (95, 96).  While drugs with anorectic and anti-obesogenic properties are in 
clinical use, many of these show marginal long-term efficacy or have 
unacceptable or overtly dangerous side effects.  Thus, recent strategies to 
modulate obesity have begun to target tissues that naturally regulate energy 
metabolism (85). 
Increasing energy expenditure by modulating adipose tissue activity could 
be an attractive target for therapy.  Because adult humans maintain small depots 
of brown fat capable of burning significant amounts of calorific energy (97-100), 
multiple studies have focused on the physiological and molecular mechanisms 
regulating the thermogenic capacity of adipose tissue.  These studies have 
shown that adaptive thermogenesis in brown fat can be a powerful regulator of 
systemic energy metabolism.  However, the relatively small amount of brown 
adipose (<0.4% of body weight) compared with white adipose tissue (WAT; 
which can comprise >40% of the body weight of an obese human) suggests that 
WAT may be a more tangible target. Interestingly, white adipose depots, which 
typically function to esterify free fatty acids and store excess lipids, have the 
capacity to develop into brown adipose-like tissue capable of modulating 
systemic metabolism and preventing obesity and insulin resistance (101).   
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While the phenomenon of adipose tissue “browning” is an active area of 
research, there is also considerable interest in understanding the metabolic 
changes that occur in WAT with obesity.  It is becoming increasingly clear that 
conditions of nutrient excess promote “whitening” of adipose tissue characterized 
by a decrease in mitochondrial abundance (47-49).  Hence, while promoting 
browning is one way to positively modulate metabolism, decreasing adipose 
tissue whitening could be another strategy to prevent dysregulation of systemic 
metabolism during obesity.  Indeed, the beneficial metabolic changes induced by 
drugs such as rosiglitazone and pioglitazone have been suggested to be due, in 
part, to their ability to prevent loss of mitochondria or increase mitochondrial 
function in WAT (49, 102).  Nevertheless, mitochondrial changes in WAT during 
the development of obesity have not been thoroughly examined, and it remains 
unclear how changes in adipocyte metabolism affect adipocyte hypertrophy and 
metabolic homeostasis. 
In this study, we examined WAT-specific changes in metabolism in a 
mouse model of diet-induced obesity.  Our data indicate extensive metabolic 
remodeling of WAT that precedes both the infiltration of inflammatory cells and 
overt decreases in mitochondrial abundance.  This renovation of adipocyte 
metabolism involved changes in glucose and lipid pathways that appear to favor 
fat storage and prevent excessive lipid oxidation.  The metabolite profile also 
yields evidence of osmotic stress and adipocyte inflammation.  Restructuring of 
intermediary metabolism was accompanied by biochemical and ultrastructural 
evidence of autophagy, which may promote degradation of mitochondria.  These 
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findings have important implications for understanding the metabolic effects of 
obesity on adipose tissue metabolism and suggest that targeting metabolic 
pathways that contribute to adipose tissue whitening or hypertrophy could form 
the basis for novel therapies to combat metabolic disease.   
 
Experimental procedures  
Animal studies: All procedures were approved by the University of Louisville 
Institutional Animal Care and Use Committee. C57BL/6J (wild-type; WT) mice 
were purchased from The Jackson Laboratory (Bar Harbor, ME). At 8 weeks of 
age, male mice were placed on either a 10% low fat diet (LFD; Research Diets, 
Inc., #D12450B) or a 60% high fat diet (HFD; Research Diets Inc., #D12492) for 
6 or 12 weeks. Water and diet were provided ad libitum. Body weights were 
recorded weekly.  
Metabolic phenotyping: Body composition was measured by dual-energy X-ray 
absorptiometry using a mouse densitometer (PIXImus2; Lunar, Madison, WI), 
and whole body energy expenditure; respiratory exchange ratio; food 
consumption; and locomotion, ambulatory and fine movements were measured 
using a physiological/metabolic cage system (TSE PhenoMaster System, Bad 
Homberg, Germany) (103).  Glucose and insulin tolerance tests and plasma 
levels of insulin were measured exactly as described in Sansbury et al (103).  
Adipocyte size measurements: Adipose tissue was excised at the time of 
euthanasia, and wet weight was recorded. All adipose tissue was either snap-
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frozen at –80°C or fixed in 10% formalin, paraffin embedded, and sectioned. The 
sections were stained in hematoxylin and eosin. Adipocyte cross-sectional area 
and distribution was determined using Nikon Elements software. Adipose tissue 
sections were assessed for crown-like structures as described previously (104).   
Adipose tissue metabolite profiling: WAT from the epididymal fat pads of mice fed 
LFD or HFD for 6 weeks were used for these analyses.  Prior to tissue collection, 
the mice were fasted for 16 h.  After euthanasia, the adipose tissue was removed 
and immediately snap-frozen in liquid nitrogen. Relative metabolite abundance 
was then measured by GC/MS or LC/MS as described before (103, 105). 
Metabolites with missing values were imputed by replacing missing values with 
half of the minimum positive value in the original data.  After a generalized 
logarithm transformation, the data were autoscaled, i.e., mean-centered and 
divided by the standard deviation of each variable.  This step was performed to 
transform the intensity values so that the distribution was more Gaussian.  
Univariate (e.g., volcano plots), multivariate (e.g., PLS-DA), and cluster (heatmap 
and dendogram) analyses were then performed. Most analyses were performed 
using Metaboanalyst 2.0 software (http://www.metaboanalyst.ca/) (106); z-score 
plots were constructed in GraphPad 5.0 software.    
Adipose tissue bioenergetic measurements: The oxygen consumption rate 
(OCR) of intact WAT explants was measured using a Seahorse XF24 analyzer 
(Seahorse Bioscience, Billerica, MA) as described previously (103). At least two 
replicates from each animal were used for the assay. After baseline 
measurements, the maximal OCR was measured by exposing the explants to 
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FCCP (10 µM).  The non-mitochondrial OCR was measured following injection of 
antimycin A (25 μM) and rotenone (5 μM).  
Citrate synthase activity assay: Citrate synthase assay was performed in 100 mM 
Tris-HCl, pH 8.0, containing 1 mM EDTA, 1 mM 5', 5'-dithiobis 2-nitrobenzoic 
acid, 10 mM acetyl-CoA. The reaction was initiated by addition of 10 mM 
oxaloacetate. Cuvettes were warmed to 37°C, and upon addition of 10 μg of 
protein from WAT lysates, absorbance at 420 nm was measured for 10 min. 
Activity is expressed as nmoles/min/μg protein.  
Expression analyses: For quantitative RT-PCR, RNA was extracted from tissues 
using the RNeasy lipid tissue kit (Qiagen), followed by cDNA synthesis. Real-
time PCR amplification was performed with SYBR Green qPCR Master Mix (SA 
Biosciences) using a 7900HT Fast Real-Time PCR System (Applied Biosystems) 
and commercially available primers for Il1, Tnfa, Il6, Arg1, Il10, Ym1, Hif1a, 
Emr1, Pgc1a, Cytc, Sirt1, Sirt3, Pdk4, Cpt1a, Cpt1b, Cox7a1, Hprt, and Idh3a 
(SA Biosciences). Relative expression was determined by the 2−ΔΔCT method. M1 
macrophages in WAT were measured by flow cytometry as described previously 
(104).   
For measuring protein abundance, WAT homogenates were prepared as 
described in Horrillo et al. (107). Equal amounts of protein were separated by 
SDS-PAGE, electroblotted to PVDF membranes, and probed using primary 
antibodies according to the manufacturers’ protocol.  The following antibodies 
were used: ALDH2 (Abcam), Sirt3 (Cell Signaling), MitoProfile® Total OXPHOS 
Rodent WB Antibody Cocktail (Mitosciences), COX4I1 (Cell Signaling), GAPDH 
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(Cell Signaling), Parkin (Abcam), Pink1 (Cell Signaling), p62 (Cell Signaling), 
LC3 (Cell Signaling), protein-ubiquitin (Cell Signaling) and α-tubulin (Cell 
Signaling).  Fluorescent or HRP-linked secondary antibodies (Invitrogen) were 
used to detect and visualize the protein bands with a Typhoon 9400 variable 
mode imager (GE Healthcare). Band intensity was quantified using Image Quant 
TL® software. 
Relative mitochondrial DNA (mtDNA) measurements: Mitochondrial abundance 
in adipose tissue was estimated by measuring mtDNA abundance, relative to 
nuclear DNA (nDNA) (108). Total DNA was isolated from WAT using a QIAamp 
DNA Mini Kit (Qiagen).  A 25 mg aliquot of the tissue was homogenized followed 
by overnight digestion in Proteinase K at 55°C.  Following isolation, relative 
amounts of mtDNA and nDNA were compared using quantitative real-time PCR 
using 2 ng of the isolated DNA. Primers for cytochrome b (mtDNA) and β-actin 
(nDNA) were used; the sequences are: cytochrome b, 5’-
TTGGGTTGTTTGATCCTGTTTCG-3’ and 5’-
CTTCGCTTTCCACTTCATCTTACC-3’; β -actin, 5’-
CAGGATGCCTCTCTTGCTCT-3’ and 5’-CGTCTTCCCCTCCATCGT-3’.  
Electron microscopy: Adipose tissues were fixed with 3% glutaraldehyde in 0.1 M 
sodium phosphate buffer (pH 7.4) for 4 h at room temperature (25°C). The 
tissues were then post-fixed with 1% osmium tetroxide for 1 h, 
dehydrated,  embedded in Embed-812 plastic (Electron Microscopy Sciences). 
Ultrathin sections were stained with uranyl acetate and Reynolds lead citrate, 
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and electron micrographs were taken using a Philips CM10 transmission electron 
microscope operating at 80 kV. 
Statistical analyses: Data are mean ± SEM.  Unpaired Student’s t test was used 
for direct comparisons. Statistical analyses for metabolomic datasets were 




High fat diet increases adiposity and alters systemic metabolism: Wild-type 
C57BL/6J mice were placed on a LFD or HFD for 6 weeks. Significant weight 
gain occurred as early as 1 week on HFD, and the change in total body mass 
was nearly 10 g by 6 weeks on the diet (Figure 1A). Food and water intake were 
not significantly different between groups (Figure 1B&C). Dexascan analysis 
showed a 2-fold increase in % fat mass and a concomitant decrease in % lean 
mass in HF-fed mice (Figure 1D&E).  These results are typical of this commonly 
utilized model of diet-induced obesity (103, 109).  
To determine how diet affects systemic metabolism, mice fed either LFD 
or HFD for 6 weeks were placed in metabolic chambers, and their oxygen 
consumption (VO2), carbon dioxide production (VCO2), and physical activity were 
measured. As shown in Figure 1F and G, average VO2 and VCO2 values 
decreased in HF-fed mice compared with mice fed a LFD. The respiratory 
exchange ratio (RER) was also decreased in HFD mice versus mice fed LFD 
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(Figure 1H).  Physical activity, measured by total beam breaks (Figure 1I), 
ambulatory counts (Figure 1J), and fine movements (Figure 1K), were not 
significantly different between groups, although the group fed a HFD appeared to 
show a trend toward decreased activity.  Consistent with our previous results 
(103), mice fed a HFD also demonstrated worsened glucose and insulin 
tolerance (Figure 2) as well as a significant increase in plasma insulin levels (WT 
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Figure 1: Effects of high fat diet on weight gain, adiposity and systemic 
metabolism. Male WT C57BL/6J mice were fed a low fat diet (LFD, 10% kcal 
fat) or high fat diet (HFD, 60% kcal fat) for 6 weeks and the following 
measurements were recorded: (A) mouse weights during 6 weeks of feeding, n = 
20 per group; (B) food intake, n = 7 per group; (C) water intake, n = 7 per group; 
(D) representative DexaScan images; (E) percentages of lean mass and body 
fat, n = 10 per group; and (F) average oxygen consumption (VO2); (G) average 
carbon dioxide production (VCO2); (H) respiratory exchange ratio (RER); (I) total 
activity level; (J) ambulatory counts; and (K) fine movements. n = 7 per group; 
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Figure 2: Glucose and insulin tolerance in mice fed low fat or high fat diets. 
After 6 weeks of a low fat (LFD) or high fat diet (HFD), glucose tolerance and 
insulin sensitivity were examined: (A) Glucose tolerance test (GTT); (B) GTT 
area under the curve (AUC); (C) insulin tolerance test (ITT) shown as % of 
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Robust macrophage infiltration does not occur with 6 weeks of HFD:  To examine 
the effects of HFD on macrophage infiltration, we placed mice on LFD or HFD for 
6 or 12 weeks and measured adipocyte size, crown-like structures that are 
indicative of macrophage infiltration, as well as the expression of inflammatory 
genes.  As shown in Figure 3A–C, mice fed a HFD for 6 and 12 weeks showed a 
3- to 4-fold increase in adipocyte size when compared with LFD controls.  While 
sections of WAT derived from mice fed a HFD for 12 weeks showed obvious 
increases in crown-like structures, WAT from mice fed HFD for 6 weeks showed 
minimal increases in such structures. These observations suggest that with 6 
weeks of HFD, there is minimal macrophage accumulation.  Indeed, the 
expression of Emr1—a marker of macrophages—as well as that of other 
inflammatory genes was not changed with 6 weeks of HFD (Figure 3D).  
Moreover, the abundance of M1 macrophages in adipose tissue stromal vascular 
fractions was not different between mice fed different diets 
(F4/80+/CD11c+/CD301- cells as %F4/80+ cells: LFD 37.4±3.5; HFD, 45.9±1.8; n 
= 9–10 per group, p>0.05.).  Most likely, the modest, insignificant increase in 
Tnfa is due to adipocytes, which have been shown to be capable of producing 
TNF-α (110, 111).  In addition, no increase in plasma levels of inflammatory 
mediators such as IL-6 were identified at 6 weeks of HFD (IL-6 (pg/ml): LFD, 
23.6±7.5; HFD, 18.8±4.2).  Collectively, these data show that adipocyte size was 
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Figure 3: Effect of HFD on adipose tissue expansion and inflammation. 
Morphological and molecular changes in adipose tissues: (A) Representative 
hematoxylin and eosin stains of epididymal adipose tissue from mice fed a LFD 
or HFD for 6 or 12 weeks; inset shows a crown like structure (CLS) in the 12 
week HFD group; (B) average area of adipocytes; (C) adipocyte size distribution; 
and (D) qRT-PCR analyses of markers of inflammation in adipose tissues from 





 39  
 
Obesity alters the metabolite profile of adipose tissue:  To examine the effect of 
obesity on adipose tissue metabolism, epididymal WAT from mice fed a LFD or 
HFD for 6 weeks was subjected to unbiased metabolomic analysis.  The relative 
concentration of adipose metabolites was measured by mass spectrometry and 
queried against the Metabolon reference library.  It is important to note that the 
composition of adipose tissue derived from mice fed LFD differed from mice fed 
HFD. In comparison with the LFD group, the protein yield per mg wet weight was 
43% lower in the adipose tissue of the HFD group (µg protein/mg wet weight: 6 
wk LFD, 10.86±1.70; 6 wk HFD, 6.21±1.28; n = 10–12 per group).  Hence, for 
metabolomic analyses, we corrected for this difference in protein content.  Partial 
least squares-discriminant analysis (PLS-DA) with the corrected data showed 
that the LFD samples separate clearly from HFD samples (Figure 4A), and 
cluster analysis showed that the abundance several metabolites was associated 
with diet (Figure 4B).  Of the 191 metabolites measured, 49 were found to be 
significantly different (p<0.05) in the WAT of mice fed a HFD compared with the 
adipose tissue from mice fed LFD.  Volcano plot analysis, using data corrected 
for protein content, showed significantly higher levels of 34 metabolites and 
significantly lower levels of 15 metabolites in adipose tissue of HF-fed mice 
compared with those fed LFD (Figure 4C and Table 1).  Volcano plot analysis 
based on uncorrected, raw data showed a large skew towards decreased 
abundance of most metabolites (Figure 4C, inset).  To visualize the data in the 
biological context of metabolic pathways, metabolites that were statistically 
different in each group were analyzed using the MetPA tool of Metaboanalyst 2.0 
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software.  The pathways were calculated as the sum of the importance measures 
of the matched metabolites normalized by the sum of the importance measures 
of all metabolites in each pathway (105, 112).  As shown in Figure 4D, the 
highest pathway impact values were related to linoleic acid metabolism and Phe, 
Tyr, and Trp metabolism.  Branched chain amino acids (BCAA) i.e., Val, Leu, and 
Ile, and pathways related with taurine metabolism; glycerolipid metabolism; Ala, 
Asp and Glu metabolism; carbohydrate metabolism; and pyrimidine metabolism 
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Figure 4: Metabolomic analyses of adipose tissue.  Metabolomic analyses of 
epididymal adipose tissue metabolites from WT mice fed a LFD or HFD for 6 
weeks: (A) Multivariate analysis: partial least squares-discriminant analysis (PLS-
DA); inset shows PLS-DA analysis from the uncorrected dataset (B) Hierarchial 
clustering: Heatmap and dendogram; (C) Univariate analysis: Volcano plot of 
metabolites. Those metabolites that were significantly higher in abundance are in 
the quadrant shaded red and those that were significantly lower are shaded 
green (p<0.05, t-test). The identity of these metabolites is found in Table 1. The 
inset shows volcano plot analysis using data that were not corrected for protein 
content; (D) Metabolites found to be significantly different were subjected to 
pathway impact analysis using Metaboanalyst MetPA and the Mus musculus 
pathway library. Fisher’s exact test was used for overrepresentation analysis, 
and relative betweenness centrality was used for pathway topology analysis. n = 
14 animals: 7 WT LFD and 7 WT HFD. 
  
 
 43  
 
Table 1   




p value FDR 
*stearoyl sphingomyelin 2.8 0.000542 0.010414 
*glycerophosphoethanolamine 2.7 7.09E-08 1.36E-05 
*succinate 2.34 0.000139 0.006385 
inosine 5'-monophosphate (IMP) 2.27 0.016131 0.088492 
uridine monophosphate (5' or 3') 2.26 0.009442 0.064744 
dihomo-linoleate (20:2n6) 2.03 0.011868 0.071209 
pelargonate (9:0) 2.02 0.030984 0.14203 
*cytidine 5'-monophosphate (5'-CMP) 1.95 0.000214 0.006839 
*Isobar: fructose 1,6-diphosphate, glucose 1,6-
diphosphate, myo-inositol 1,4 or 1,3-diphosphate 
1.87 0.000166 0.006385 
maltose 1.86 0.03107 0.14203 
docosapentaenoate (n3 DPA; 22:5n3) 1.83 0.033432 0.14928 
*glutamate 1.81 0.000111 0.006385 
glucose 1.8 0.005764 0.046111 
azelate (nonanedioate) 1.75 0.001215 0.01795 
dihomo-linolenate (20:3n3 or n6) 1.75 0.006864 0.052713 
stearate (18:0) 1.74 0.003972 0.038131 
arachidonate (20:4n6) 1.68 0.001536 0.021059 
deoxycarnitine 1.64 0.000539 0.010414 
glycerophosphorylcholine (GPC) 1.64 0.005243 0.045087 
hypotaurine 1.62 0.024921 0.12592 
12-HETE 1.61 0.036945 0.16121 
acetylcarnitine 1.54 0.000362 0.008923 
margarate (17:0) 1.51 0.046138 0.18455 
aspartate 1.47 0.003862 0.038131 
creatine 1.46 0.000666 0.01162 
malate 1.45 0.008981 0.063867 
linoleate (18:2n6) 1.42 0.026561 0.13076 
palmitoyl ethanolamide 1.38 0.02444 0.12592 
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propionylcarnitine 1.37 0.048868 0.18902 
taurine 1.33 0.001968 0.024159 
glutamine 1.32 0.000372 0.008923 
choline phosphate 1.32 0.011199 0.06936 
citrulline 1.29 0.002367 0.025244 
cholesterol 1.28 0.002251 0.025244 
*leucine 0.79 0.005401 0.045087 
*tyrosine 0.78 0.042828 0.18273 
pantothenate 0.73 0.049223 0.18902 
mead acid (20:3n9) 0.66 0.028737 0.13794 
phenylalanine 0.62 0.011086 0.06936 
valine 0.6 0.00483 0.044159 
3-dehydrocarnitine 0.58 0.013332 0.077568 
1,5-anhydroglucitol (1,5-AG) 0.56 0.010344 0.068482 
glucose-6-phosphate (G6P) 0.51 0.045306 0.18455 
histamine 0.46 0.017878 0.095349 
ergothioneine 0.45 0.000163 0.006385 
*N-acetylmethionine 0.35 0.002013 0.024159 
*mannose-6-phosphate 0.33 0.013998 0.079048 
*glycerate 0.07 0.008323 0.061462 
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Table 1. List of adipose tissue metabolites that changed significantly in 
high fat-fed mice. Wild-type (WT) mice were fed a low fat or high fat diet (LFD 
or HFD, respectively) for 6 weeks. Epididymal adipose tissue was then subjected 
to LC or GC mass spectrometric analysis.  Raw spectral values from WAT of HF-
fed mice were corrected based on the mean difference in protein content (per mg 
wet weight) compared with WAT from LF-fed mice.  Adipose tissue metabolites in 
HF-fed mice that were at least 25% changed in abundance and significantly 
different (p<0.05) compared with LF-fed mice are shown. n = 7 mice per group; 
*indicates those metabolites that were significant even when ±2 SEM were 
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To delineate changes in metabolites further, metabolites were categorized based 
on superfamily class, and z-score plots were constructed.  As shown in Figure 5, 
the abundance of multiple lipid superfamily members, including those involved in 
glycerolipid metabolism and linoleic acid metabolism was higher.  Several 
carnitine derivatives, with the sole exception of 3-dehydrocarnitine, were higher 
in abundance as well.  In the amino acid superfamily, the levels of non-essential 
amino acids Glu, Gln and Asp were elevated, and those of essential amino acids 
Phe, Leu and Val were lower.  Notably, the organic osmolytes—taurine, 
hypotaurine and creatine—were more abundant.   In the HFD group, levels of the 
Krebs cycle intermediate succinate were higher; levels of malate were higher as 
well, although pantothenate, a precursor to Coenzyme A (CoA), was less 
abundant. While both glucose and maltose levels were higher, phosphorylated 
sugars were diminished. Plasma 1,5-anhydroglucitol (1,5-AG), which is present 
in most organs and tissues and has been shown to decrease with loss of 
glycemic control (113, 114), was diminished in abundance, which is in agreement 
with insulin resistance in skeletal muscle and liver occurring at 6 weeks of HFD 
(109). Interestingly, the pyrimidine monophosphates cytidine-5’-monophosphate 
(CMP) and uridine monophosphate (UMP), as well as the purine inosine-5’-
monophosphate, were elevated in WAT from HF-fed mice.  A graphical 
illustration of these changes, placed into context of known pathways of 
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Figure 5: Z-score plot analysis of metabolite changes in adipose tissue 
from high fat fed mice. Mice were fed a LFD or HFD for 6 weeks. Data are 
shown as standard deviations from the mean of LFD. Z-scores of some 
metabolites were not plotted due to lack of detectable signal in either LFD or 
HFD groups, e.g., glycylleucine, glycerate. Each point represents one metabolite 
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Figure 6:  Illustration of metabolite changes in adipose tissues of obese 
mice.  Metabolic changes in adipose tissue that occur with HFD are shown in the 
context of known metabolic pathways. In red are those metabolites that 
increased, and in green (and underlined) are those metabolites that decreased, 
in obese mice.  12-HETE, 12-Hydroxyeicosatetraenoic acid; BCAAs, branched 
chain amino acids; CoA, coenzyme A; CMP, cytidine 5’-monophosphate; DHAP, 
dihydroxyacetone phosphate; FAs, fatty acids; F6P, fructose-6-phosphate;  F-
1,6-P2, fructose-1,6-bisphosphate; G3P, glycerol-3-phosphate; G6P, glucose-6-
phosphate; GA3P, glyceraldehyde-3-phosphate; GPC, glyerophosphorylcholine; 
GPE, glycerophosphoethanolamine; IMP, inosine 5’-monophosphate; UMP, 
uridine monophosphate (5’ or 3’). *isobaric entity: Metabolite identity is unclear 
from the data and could be either F-1,6-P2, glucose-1,6-diphosphate, or myo-
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Effect of obesity on oxygen consumption and mitochondrial remodeling in WAT: 
The changes in energy metabolism found in our metabolomic analyses 
suggested that HFD might have altered adipose tissue bioenergetics.  
Importantly, these changes occurred in the absence of inflammatory cell 
infiltration (see Figure 3), which could otherwise confound adipocyte-specific 
changes in metabolism. To determine how obesity affects mitochondrial function, 
WAT explants from mice fed a LFD or HFD were subjected to extracellular flux 
analysis.  As shown in Figure 7A and B, the apparent basal mitochondrial oxygen 
consumption rate of adipose tissue derived from mice fed a LFD was >2-fold 
higher when compared with adipose explants derived from HF-fed mice (p<0.05); 
however, after correction for protein content, there was no difference in 
mitochondrial oxygen consumption.  Nevertheless, explants derived from mice 
fed a HFD responded more strongly to FCCP (Figure 7C).  Although citrate 
synthase activity was lower by more than 50% in WAT derived from these mice 
(Figure 7D), relative abundance of mtDNA, as assessed by qPCR of mtDNA 
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Figure 7: Obesity-related energetic changes in white adipose tissue.  
Metabolic analysis of adipose tissue from mice fed a LFD or HFD for 6 weeks: 
(A) Extracellular flux analysis: After three basal oxygen consumption rate (OCR) 
measurements, FCCP (10 µM) was injected, followed by injection of antimycin A 
(AA, 25 μM) and rotenone (Rot, 5 μM). Gray circles indicate values from HF-fed 
mice that were corrected based on differences in protein content compared with 
LF-fed mice. For clarity, error bars were omitted from the HFD corrected group. 
Dotted lines indicate ±2SEM from corrected values.  (B) Detailed changes in 
basal, maximal (Max.), non-mitochondrial (N.M.), basal mitochondrial (Mitobasal), 
and maximum mitochondrial (Mitomax) rates of oxygen consumption; (C) FCCP 
response: the FCCP response in each explant was calculated using the 
equation: (OCRMAX/OCRBASAL) × 100; n = 10 mice per group; (D) citrate synthase 
activity, n = 3-6 mice per group; (E) Relative mtDNA content, n = 6 per group. 
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The observed changes in metabolite profile, increased mitochondrial 
responsiveness to FCCP, and diminished citrate synthase activity suggested that 
HFD might affect the expression of genes associated with metabolic activity. 
Indeed, the expression of Cox7a1, a subunit in the electron transport chain, was 
more than 2-fold higher in adipose tissue from mice fed a HFD, whereas the 
expression of Pgc1a, Sirt3, and Pdk4 expression was diminished (Figure 8A), 
indicating mitochondrial remodeling despite preserved basal mitochondrial 
activity.     
To further understand how WAT mitochondria change with obesity, we 
assessed the relative abundance of several mitochondrial complex proteins as 
well as mitochondrial matrix proteins. Although no changes in mitochondrial 
protein abundance were observed at 6 weeks of HFD, the protein levels of 
NDUFB8, SDHB, and COX4I1—subunits of complexes I, II, and IV, 
respectively—were diminished significantly by 12 weeks of HFD (Figure 8B–E). 
The levels of the matrix proteins – ALDH2 and Sirt3 – showed similar trends, with 
ALDH2 being significantly lower after 12 weeks of HFD.   
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Figure 8:  Obesity-related changes in mitochondrial protein abundance in 
white adipose tissue.  Analysis of gene expression and protein abundance 
adipose tissue from mice fed a LFD or HFD for 6 or 12 weeks: (A) Expression of 
metabolic genes; (B) Representative Western blots of mitochondrial matrix 
proteins and respiratory chain subunits; (C) Quantification of ALDH2; (D) 
Quantification of Sirt3; (E) Quantification of respiratory subunit abundance.  All 
blots were normalized to ATP5A, which showed no change in abundance in any 
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Assessment of adipose tissue ultrastructure: To determine subcellular changes 
that occur in adipose tissue of nutrient-stressed mice, we examined adipocyte 
ultrastructure using electron microscopy. As shown in Fig 9A, adipose tissue 
from mice fed a LFD showed mitochondria with three distinct morphologies: a 
round morphology of small size that was located near the nucleus (Figure 9A-i,ii); 
a typical elongated shape up to ~0.7 μm in length located in small protrusions 
along the adipocyte cell membrane (Figure 9A-iii); and long mitochondria (up to 5 
μm and above), which were located in juxtaposition to the fat locule (Figure 9A-
iv).  In adipocytes derived from HF-fed mice, autophagosomes—defined by a 
double-membrane and comprising cytoplasmic constituents—were found next to 
mitochondria (Figure 9B-i), and large vacuoles of electron-dense material were 
found adjacent to autophagosomes (Figure 9B-ii,iii). In addition, many 
mitochondria in adipose tissues from HF-fed mice appeared to be undergoing 
fission (Figure 9B-iv,v).     
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Figure 9:  Ultrastructure of white adipose tissues from lean and obese 
mice. Representative transmission electron micrographs of epididymal adipose 
tissues derived from mice fed a LFD or HFD for 6 weeks. (A) Ultrastructure of 
mitochondria in adipose tissues from LF-fed mice: (i) micrograph of adipocytes in 
areas close to the nucleus; (ii) higher magnification of panel i; (iii) a cytosolic 
compartment containing a mitochondrion found protruding into the fat locule; and 
(iv) an elongated mitochondrion in juxtaposition to the fat locule. (B) 
Ultrastructure of adipose tissue derived from HF-fed mice: (i) An elongated 
mitochondrion next to an autophagosome; (ii) an autophagosome in close 
proximity to a vacuole containing electron-dense material; (iii) magnified image of 
panel ii; (iv) protrusion of cytosolic compartment containing an atypical 
mitochondrion; and (v) mitochondrion that appears to be undergoing fission. 
Asterisks (*) indicate autophagosomes; small arrows indicate collagen; 
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Effects of HFD on autophagy: Changes in citrate synthase and mitochondrial 
proteins, along with the ultrastructural alterations found to occur in the adipose 
tissue, suggest that HFD may promote mitochondrial remodeling and activate 
mitophagy in WAT.  To examine this possibility, we measured markers of 
mitophagy and autophagy in adipose tissues from mice fed a LFD or HFD for 6 
weeks.  Levels of the E3 ubiquitin ligase Parkin, which has been shown to 
accumulate in mitochondria destined for degradation (115), were 2.3-fold higher 
with 6 weeks of HFD and nearly 2-fold higher after 12 weeks of HFD (Figure 
10A,B).  Furthermore, the kinase Pink1—critical for identifying mitochondria 
destined for autophagy (115)—was also nearly 40% higher in the HFD groups. In 
combination with the presence of autophagosomes and mitochondrial alterations 
observed by EM (Figure 9), this observation suggests that metabolic remodeling 
of adipocytes in the expanding adipose organ may be related to autophagy.  To 
address this possibility, we measured changes in protein indicators of autophagy. 
As shown in Figure 10C–H, levels of p62 and LC3-I were diminished significantly 
and the LC3-II:LC3-I ratio was more than 2-fold higher in mice fed a HFD for 6 
weeks in comparison with those placed on LFD.  However, there was no 
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Figure 10: Evidence for activation of mitophagy in WAT of obese mice.  
Immunoblot analysis of markers of mitophagy and autophagy: (A) Western blots 
of Parkin and Pink 1 in adipose tissues from mice fed a LFD or HFD for 6 weeks 
(left panels) or 12 weeks (right panels); and (B) Quantification of Parkin and 
Pink1 abundance from panel E. n = 4 per group; *p<0.05 vs. LFD. n = 4 per 
group; (C) Representative Western blots of ubiquitinated proteins, p62, and LC3 
in mice fed a LFD or HFD for 6 weeks.  (D–H) Quantification of protein-ubiquitin 
abundance, p62, LC3-I, LC3-II abundance, and LC3-II/LC3-I ratio.  n = 10 per 
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Discussion 
The results of this study demonstrate coordinated restructuring of adipose 
tissue metabolism during adipocyte hypertrophy.  Using metabolomics analysis, 
we identified several HFD-induced changes in key metabolites involved in 
energy, carbohydrate, nucleotide, lipid and amino acid metabolism.  Importantly, 
these changes were relatively independent of inflammatory cell infiltration, and 
the data were corrected for adipocyte content; both of which help eliminate 
confounding features related to tissue and adipocyte composition. Our analysis 
showed an early decrease in citrate synthase activity that coincided with reduced 
expression of Pgc1a, even though mitochondrial abundance was not affected.  
Ultrastructural and immunological evidence suggested that whitening of the 
adipose tissue, evident after 12 weeks of HFD, may also be related to 
autophagy, which appears to occur early after adipocytes attain near maximum 
size.  Taken together, these results reveal that conditions of nutrient excess 
promote progressive metabolic remodeling, decreased capacity for mitochondrial 
biogenesis, and potential activation of the autophagic program in WAT.   
 The major goal of this study was to understand how HFD affects adipose 
tissue biology and metabolism.  This is important because key metabolic 
changes that occur during adipocyte hypertrophy could be targets for anti-obesity 
or insulin-sensitizing therapies. We found that 6 weeks of HF feeding led to a 
profound increase in fat mass, which was accompanied by a decrease in 
systemic VO2, VCO2 and RER, and insulin resistance. Although adipose tissue 
inflammation is evident by the 10th-12th week of HFD (116, 117), we find no 
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significant increase in inflammatory cell infiltration with 6 weeks of HFD  (e.g., 
see Figure 3 and (109, 117)).  This lack of extensive tissue infiltration by 
energetic inflammatory cells allowed us to examine HFD-induced changes 
specific to the adipose tissue.   
Moreover, in our metabolic measurements, we accounted for changes in 
the composition of the adipocytes themselves. Because white adipocytes expand 
by storing triglycerides in the central lipid droplet, an equivalent tissue mass of 
WAT from a HF-fed mouse comprises fewer cells (and more triglyceride) than 
adipose tissue from a LF-fed mouse.  Thus, normalization of metabolite levels by 
wet weight alone could lead to erroneous conclusions.  An example of this is 
shown in Figs. 4 and 6, where uncorrected values  indicate that most metabolites 
are decreased in WAT from HF-fed mice (Figure 4E, inset) and that 
mitochondrial OCR is diminished in adipocytes from the obese mice (Figure 
7A&B).  Correcting for protein content in samples from HF-fed mice normalized 
the distribution of metabolic changes and rectified the leftward skew caused by 
decreased adipocyte content. Similarly, when values were normalized for protein 
content (rather than mg wet weight), there was no difference in tissue oxygen 
consumption between explants from LFD and HFD groups.  This indicates that, 
with 6 weeks of HFD, there was no change in basal mitochondrial oxygen 
consumption per adipocyte.   
Our metabolic profiling indicates that HFD affects several metabolic 
pathways.  In mice placed on HFD for 6 weeks, we found significant changes in 
lipid, amino acid, energy, nucleotide, and carbohydrate metabolism. Higher levels 
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of several fatty acids and lipid metabolites belonging to the linoleic acid 
metabolism subfamily were observed in WAT from HF-fed mice.  In this tissue, 
there was also a higher abundance of arachidonic acid as well as metabolites 
involved in arachidonic acid synthesis, including linolenic acid and dihomo-
linolenic acid, which indicates a coordinated upregulation of this pathway.  WAT 
from HF-fed mice also contained higher levels of the eicosanoid 12-
hydroxyeicosatetraenoic acid (12-HETE), which is formed from arachidonate by 
12/15-lipoxygenase (12/15-LO).  Interestingly, 12/15-LO is upregulated in white 
adipocytes of both HF-fed C57BL/6J mice (118) as well as Zucker obese rats 
(119). Thus, upregulation of 12/15-LO and increased production of its product 
(12-HETE) are consistent features of hypertropic WAT.  This may be particularly 
significant in mediating adipose tissue dysfunction because two separate studies 
have shown that genetic deletion of 12/15-LO prevents HFD-induced adipose 
tissue inflammation and insulin resistance (120, 121).   
The elevated levels of glycerophosphoethanolamine (GPEA) in WAT from 
obese mice could be due to an increase in the breakdown of 
phosphatidylethanolamine or a decrease in its rate of hydrolysis.  Previous 
studies have shown that GPEA is hydrolyzed by enzymes such as 
glycerophosphodiester phosphodiesterase to form glycerol-3-phosphate (G3P) 
(122), which is required for triglyceride synthesis and thus would likely be in high 
demand in expanding adipocytes (123).  Glycerophosphorylcholine (GPC), which 
was elevated in WAT from HF-fed mice, could also be utilized to form G3P.  
However, a major function of GPC in the cell is to act as an organic osmolyte 
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(124), suggesting that there might be an increase in osmotic stress in 
hypertrophic adipocytes. This view is supported by our observation that the levels 
of several major osmolytes such as taurine, hypotaurine and creatine were 
higher in WAT from obese mice.  Changes in osmolality could trigger a form of 
cell death called pyroptosis (125), which has been linked with inflammasome 
activity (126).  Interestingly, the NLRP3 inflammasome is activated by cholesterol 
crystals, and, consistent with previous observations in hypertrophied adipocytes 
(127, 128), our analyses also showed an elevation of cholesterol in adipose 
tissue of obese mice.  Collectively, these observations suggest an early increase 
in key metabolic instigators that could contribute to osmotic stress and 
inflammation in adipose tissue. 
The HFD-induced increase in stearoyl sphingomyelin could further prime 
adipocytes for inflammation and metabolic dysfunction. Sphingomyelin (SM; 
d18:1/18:0)—which in humans is the only membrane phospholipid not derived 
from glycerol—is a type of sphingolipid found in cell membranes that consists of 
oleic acid attached to the C1 position and stearic acid attached to the C2 
position. Genetic deletion of enzymes involved in sphingomyelin synthesis has 
been shown to protect against diet-induced obesity and insulin resistance (129, 
130), and the breakdown of sphingomyelin could yield significant amounts of 
ceramide, which inhibits insulin signaling (131).  Hence, the elevated levels of 
sphingomyelin observed in our study could prime adipocytes to release 
significant amounts of ceramide, which has been shown to be increased by 
300% in both the plasma and the adipose tissue by HFD (132).  Although 
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ceramide levels were not measured in our analyses, we did observe a decrease 
in Pgc1a expression and a decrease in citrate synthase activity, both of which 
can be regulated by ceramide (133, 134). However, further studies are required 
to determine whether changes in mitochondrial biogenetic capacity and citrate 
synthase activity are related to high levels of stearoyl sphingomyelin.  
Our metabolomic data suggest significant changes in intermediary 
metabolism related to energy expenditure and fat storage.  We found that many 
carnitine derivatives were increased in WAT from HF-fed mice. These include 
acetylcarnitine, proprionylcarnitine, and deoxycarnitine; although 3-
dehydrocarnitine, an intermediate in carnitine degradation, was diminished.  
These changes suggest the presence of a “flooded” pool of adipocyte 
metabolites, which could be used for either energy provision, or, more likely, as a 
temporary repository for substrates for fatty acid synthesis.  In other tissues such 
as the heart, acetylcarnitine functions as a buffer of the acetyl CoA pool, although 
it could be used as an energetic substrate as well (135).  Similarly, the 
propionylcarnitine could buffer the propionyl CoA pool (136). Thus, it appears 
that in expanding adipocytes short-chain acylcarnitine pools could help buffer 
excess carbon until it is assimilated into fatty acids for triglyceride storage.   
The observations that tissue levels of BCAAs such as leucine and valine 
were decreased, while propionylcarnitine and succinate levels were increased 
with HFD, suggest an increase in BCAA catabolism.  Catabolism of BCAAs 
results in the formation of both acetyl CoA and succinyl CoA, the latter can be 
converted to succinate, which in our analysis was elevated in WAT from HF-fed 
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mice.  Thus, it is likely that in hypertrophic adipocytes there is increased 
utilization of BCAAs.   In contrast to the decrease in BCAAs, we found that levels 
of Gln and Glu were increased with HFD.   This increase may be particularly 
important, given the multifaceted uses of glutamine, e.g., in anaplerotic 
metabolism, as a nitrogen donor in anabolic processes, as well as a precursor for 
glutathione synthesis (137, 138). In addition, Gln and Asp are required for 
synthesis of several nucleotides such as IMP, UMP and CMP, all of which were 
increased in these studies. Interestingly, adipose tissue is a major site of 
glutamine synthesis, and its uptake can be regulated by changes in osmolality as 
well as by insulin (139).    
Although there is a clear relationship between amino acids, insulin 
resistance and obesity in animal models and humans (140-142), the mechanistic 
basis of this link is less clear.  BCAA metabolism in adipose tissue modulates 
plasma BCAA levels (143), and, interestingly, increasing circulating BCAAs in 
mice by preventing BCAA catabolism prevents diet-induced obesity and insulin 
resistance in mice (144), whereas feeding BCAAs to HF-fed rats increases 
insulin resistance (142).  While further studies are required to test the full 
significance of such metabolic changes in BCAAs and other amino acid 
pathways, it is possible that changes in amino acid catabolism and downstream 
metabolites have novel roles in adipose tissue biology such as the regulating lipid 
storage and release. This possibility is supported by a recent report showing that 
succinate, which can be derived from BCAA breakdown, inhibits lipolysis by 
activating Gpr91 (a succinate receptor) (145).   
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Metabolites related with glucose metabolism were also markedly affected 
by HFD.  We found a nearly 50% decrease in the abundance of 1,5-AG in WAT 
samples from HF-fed mice.  Plasma 1,5-AG is a validated marker of short-term 
glycemic control and has been suggested to be in equilibrium in tissue and 
plasma pools (113, 114). Hence, even though 6 weeks of HFD does not appear 
to significantly affect fasting blood glucose levels (103), the decreased 
abundance of 1,5-AG is consistent with systemic insulin resistance and poor 
glycemic control (109).  With respect to glycolysis, glucose-6-phosphate was 
decreased, and adipose tissue glucose was increased, suggesting that 
hexokinase might be a major rate-limiting step in the provision of glucose 
carbons required for triglyceride synthesis.  Further evidence of changes in 
glucose metabolism is shown by diminished pdk4 expression, which regulates 
pyruvate dehydrogenase activity. This decrease in pdk4 could potentially 
promote glyceroneogenic formation of G3P (146) via cataplerosis (147).   
Interestingly, while we observed no change in basal mitochondrial OCR 
when corrected for protein content, WAT from HF-fed mice showed an increased 
response to FCCP.  We speculate that once metabolic restraint due to Δp is lifted 
(by addition of uncoupler), the increased substrate available for oxidative 
phosphorylation, e.g., succinate, malate, glutamate, short-chain acylcarnitines, 
results in increased rates of oxygen consumption.   Also, in datasets corrected 
for protein content, there was a trend toward an increased rate of non-
mitochondrial oxygen consumption, which might suggest an increase in 
adipocyte superoxide production due to cytosolic oxidase activity (115, 148).  
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This possibility is consistent with previous studies showing an increase in 
oxidative stress in adipose tissue of obese mice, which is predominantly caused 
by an increase in NADPH oxidase and down-regulation of antioxidant enzymes  
(149-153).   
Further support for coordinated remodeling of mitochondrial and cytosolic 
metabolism is provided by the observation that expression of Cox7a1 was 
increased in the adipose tissue of obese mice.  A similar increase in Cox7a1 
gene has been shown in the WAT of fattening cattle (154), although the 
implications of this increase are currently unclear.  Cox7a1 is considered to be a 
heart- and muscle-specific subunit of cytochrome oxidase, but it is also present in 
brown adipose tissue; these tissues are highly metabolic organs capable of 
utilizing large amounts of substrate. Thus, it is possible that the increase in 
Cox7a1 may be an adaptive response to dissipate excessive energy in the 
adipocyte.  The decrease in citrate synthase activity, which provides additional 
evidence for remodeling of mitochondrial metabolism during adipocyte 
hypertrophy, is similar to that observed in db/db mice, where citrate synthase 
activity is diminished remarkably with no change in mtDNA/nDNA (155).   Why 
citrate synthase decreases in expanding adipocytes is currently unclear; 
however, it could be an adaptation to prevent excessive influx of carbon into the 
Krebs cycle, which would be consistent with the view that during obesity there is 
an overall shift in metabolism from energy provision to lipid storage. 
The notion that HFD remodels mitochondrial metabolism in adipocytes is 
further supported by diminished mitochondrial biogenetic capacity and later 
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decreases in electron transport chain protein abundance. With of 6 weeks of 
HFD, mitochondrial abundance per se was not affected; however, we did find a 
significant decrease in Pgc1a expression, which was followed by loss of 
mitochondrial protein abundance after 12 weeks of HFD.   This relatively late 
decrease in mitochondrial protein abundance may be due also to early changes 
in mitochondrial metabolism that promote removal of mitochondria by autophagy. 
Autophagy has been shown previously to be increased in adipocytes from obese 
humans and mice (156-158).  Consistent with those studies, our biochemical 
results show an increase in the LC3-II/LC3-I ratio and a decrease in p62, the 
combination of which would appear to be consistent with an increase in 
autophagic flux (159, 160).  Ultrastructural data showing autophagosomes and 
vacuolated structures containing electron-dense material further suggest 
changes in autophagy consistent with its activation.  A limitation of this study, 
however, is that autophagic flux was not directly measured, making it difficult to 
ascribe with certainty directional changes to the autophagy pathway.  
Nevertheless, an activation of autophagy in adipose tissue would be expected to 
decrease the abundance of both LC3-I and p62 (161-164), which is consistent 
with our results.  Hence, our cumulative data are supported by evidence in the 
literature and suggest that autophagy is activated by HFD.  While we cannot 
clearly distinguish whether mitochondria are removed by autophagy, the increase 
in key proteins involved in mitophagy – Parkin and Pink1 (115, 165) – would be 
consistent with a significant role of mitophagy in mediating mitochondrial 
remodeling and turnover in the WAT of obese mice.  
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In summary, in this study we identified key metabolic changes that occur 
during WAT expansion. These coordinated changes occur before the infiltration 
of inflammatory cells and include: loss of mitochondrial biogenetic capacity; 
dysregulation of lipid, amino acid, glucose, nucleotide and amino acid 
metabolism; changes in mitochondrial gene expression and protein abundance; 
and evidence of alterations in autophagy and possibly mitophagy.  Our results 
are consistent with the view that constant nutrient excess shifts adipocyte 
metabolic activity from energy provision to lipid storage.  We speculate that the 
decrease in mitochondrial biogenetic capacity and later removal of mitochondria 
may also be a response to limit excessive lipid oxidation and oxidative stress and 
to promote fat storage. Further studies are required to assess the significance of 
each of the metabolic alterations and to test whether therapeutically targeting 




















Storing lipid in the form of esterified fat is the primary function of white 
adipose tissue. Adipose tissue can expand to increase lipid uptake in two ways, 
via adipocyte hypertrophy or hyperplasia (16, 57). Adipocytes can hypertrophy to 
accommodate massive lipid loads; however when maximum expansion is 
achieved, adipocytes begin to die by way of necrosis leading to an increase in 
adipose tissue inflammation, hypoxia, and insulin resistance (56, 57, 166, 167). 
Adipose tissue expansion has been shown to occur in this manner with 
prolonged consumption of HFD (15). Adipocyte progenitor cells (APCs), which 
can give rise to mature adipocytes, have been shown to proliferate and 
differentiate allowing for expansion of adipose tissue by way of hyperplasia. This 
type of expansion appears to maintain metabolic homeostasis, suggesting 
hyperplasia is a more metabolically favorable form of adipose tissue remodeling 
(37, 66).  
Putative APCs have been described as cells expressing CD24 and CD29 
and can be isolated from both bone marrow and adipose tissue. Rodeheffer, et 
al. showed that when these cells, when transplanted into insulin resistant, 
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lipodystrophic mice, proliferated, differentiated, and gave rise to a functional 
adipose organ capable of storing lipid. The development of this tissue improved 
insulin sensitivity in the transplanted animals (37). While APCs are required to 
improve the fat storage capacity of adipose tissue, several types of supporting 
cells would be required.  For example, to sustain proper tissue oxygenation in 
expanding tissue and to nurture newly formed, APC-derived adipocytes, the 
vasculature network would need to grow in tandem with the expanding adipose 
organ.  Thus, endothelial progenitor cells (EPCs), which have been shown to 
repair damaged endothelium and support the formation of new blood vessels in 
vivo (168-171), would likely be in high demand during periods of increased fat 
storage. In mice, Sca-1+ Flk1+ cells have been identified as EPCs and are 
believed to have the capacity to differentiate into mature vascular networks, 
promote vascular stability, or support angiogenesis (71, 76).  
Chronic adipose tissue inflammation and hypoxia are known to 
accompany the development of obesity, and these processes, in addition to 
metabolic changes (15, 55, 56, 172), could negatively affect adipose tissue stem 
cell populations. Nevertheless, the impact of obesity on these cell progenitor cell 
populations is not clear. Because both an adequate amount of adipocytes and 
oxygen availability are necessary to remodel adipose tissue, we hypothesize that 
the balance of CD24+ CD29+ APCs and Sca-1+ Flk1+ EPCs is crucial for 
favorable adipose tissue expansion. A better understanding the changes that 
occur in progenitor cell populations of adipose tissue could be beneficial in 
determining new treatments for obesity.  
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 To track the progenitor cell populations of interest, we performed a bone 
marrow transplant, replacing bone marrow of wild-type mice with GFP positive 
bone marrow cells. Donor bone marrow cells and progeny expressed GFP which 
was detectable in the stromal vascular fraction (SVF). Analysis of SVF using flow 
cytometry allowed us to quantify changes in the APC and EPC populations after 
12 weeks of HFD as well as to determine the origin of each cell type. Results 
from this study show that obesity increases the ratio of APCs to EPCs in adipose 
tissue.  Moreover, we find that more than 96% APCs are bone marrow-derived, 
unlike EPCs which appear to be primarily tissue-resident.  These data provide 
fundamental information regarding the source of stem cells in adipose tissue and 
suggest that changes in the number or function of angiogenic and adipogenic 
progenitor cell populations may be an important feature of adipose tissue 
remodeling.  
 
Experimental procedures  
Animal Studies: All procedures were approved by the University of Louisville 
Institutional Animal Care and Use Committee. All mice used in these studies 
were purchased from The Jackson Laboratory (Bar Harbor, ME).  
Four week old C57BL/6J (wild-type; WT) mice were acclimated to the 
animal facility for one week before being subjected to 10 minutes of total body 
irradiation at a dosage of 950cGy by way of a cesium source (173). Twenty-four 
hours after irradiation, bone marrow from 8 week old male mice expressing 
“enhanced” green fluorescent protein (EGFP; The Jackson Laboratory, #006567) 
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was isolated and used to transplant irradiated WT mice via a single retro-orbital 
injection. Approximately, 1×107 bone marrow stromal cells were injected into 
each mouse using 100µl sterile PBS as the vehicle (Scheme 2). Five weeks after 
transplantation, at 9 weeks of age, bone marrow transplanted (BMT) mice were 
placed on either a 10% low fat diet (LFD; Research Diets, Inc., #D12450B) or a 
60% high fat diet (HFD; Research Diets Inc., #D12492) for 12 weeks. Water and 
diet were provided ad libitum and body weights were recorded weekly. To assess 
proliferative capacity of adipose tissue-resident stem cells, 33mg/kg/day 
bromodeoxyuridine (BrdU) was administered via i.p. injection each day for 7 days 
prior to euthanasia.  
Separate cohorts of WT mice, not subjected to BMT, were maintained on 
LFD or HFD for 12 weeks. These animals received water and food ad libitum and 
body weights were measured on a weekly basis for the duration of the study. At 
the time of euthanasia, wet organ weights were measured and recorded to 
assess potential differences between study groups.  
Body composition measurement: Lean mass, fat mass, percent body fat, and 
total body mass were measured by Dual X-ray Absorptiometry (DEXAscan) 
paired with a mouse densitometer (PIXImus; Lunar, Madison, WI). For this 
measurement, the body weight of each mouse was taken prior to the scan and 
animals were anesthetized with isofluorane gas for the duration of the 
DEXAscan. Measurements for each parameter were recorded and images of 
each animal were collected.  
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Activity assessment: Total activity level, ambulatory counts, fine movements, and 
respiratory exchange ratio (RER) were measured using a physiological/metabolic 
cage system (TSE PhenoMaster System; Bad Homberg, Germany). The mice 
were singly housed throughout the entire assessment. Cages were located in a 
temperature controlled room and when the light cycle was also regulated to allow 
for 12 hours of light and 12 hours of darkness. 
Glucose and Insulin Tolerance Tests: After a 6 h fast, a bolus of glucose (1.0 
mg/g in sterile saline) was injected i.p. and blood glucose measurements were 
recorded over the course of 2 h using blood collected from the tail vein. For 
insulin tolerance tests, a bolus of insulin (1.5 U/kg Humulin R in sterile saline) 
was injected i.p. into non-fasted mice and blood glucose was measured over a 2 
h period.  
Isolation of adipose stromal vascular fraction: The stromal vascular fraction 
(SVF) was isolated from the visceral and subcutaneous adipose depots. The 
adipose tissue was finely minced and digested in collagenase (500CDU/mL 
PBS/HEPES) at 37°C for 25 min. The mixture was then filtered to remove any 
particles larger than 100 µm and washed several times to remove excess 
collagenase from the cell fraction. 
Analysis of adipose tissue by flow cytometry: SVF cells were isolated as 
previously described in this chapter and used for flow cytometric analysis. The Fc 
receptor was blocked for 10 min at 4°C to prevent non-specific antibody binding. 
The diverse SVF population was then stained for 30 min at 4°C with antibodies to 
detect each of the following cell populations: adipocyte progenitor cells (Sca-1, 
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CD24, CD29, CD90.2), endothelial progenitor cells (Sca-1, Flk1), leukocytes 
(CD45), monocytes (CD14), macrophages (F4/80, CD11c, and CD301), T cells 
(CD3, CD4, and CD8), B cells (B220/CD45R), and granulocytes (GR-1). All 
antibodies (purchased from eBioscience or Biolegend) were conjugated to 
unique fluorochromes for detection in 2 or more distinct panels. Samples were 
analyzed using the BD LSR II and FACSDiva Software. Experiment files were 
exported and further analyzed using the FlowJo analysis software.  
WT, C57BL6/J mice from the Jackson Laboratory were used as bone 
marrow cell recipients for this study. Mice expressing EGFP were used as bone 
marrow cell donors. We chose to use these mice as donors so that we could 
identify cell origin. Since donor cells expressed GFP, any cell which also 
expressed GFP was deemed to be a bone marrow-derived cell. Therefore, GFP- 
cells were deemed tissue resident cells.   
Assessment of proliferation in adipose tissue: Immunofluorescent staining of 
adipose tissue sections was performed with aid from the Pathology CORE at the 
Diabetes and Obesity Center. Staining for transplanted cells, BrdU, and cell 
nuclei were done using primary antibodies against the following proteins: GFP, 
BrdU, and DAPI, respectively. Distinct fluorescent secondary antibodies were 
used to detect each of the primary antibodies. The Zeiss confocal microscope 
belonging to the Department of Molecular Cardiology at the University of 
Louisville was used to generate images of the fluorescent-stained adipose tissue 
sections. The Carl Zeiss ZEN 2012- blue edition was used to capture and 
analyze each of the confocal images. Cell expression of GFP, BrdU, and Dapi 
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were quantified independently using the Nikon Elements-Basic Research 
software package. To determine proliferative capacity of bone marrow-derived 
cells, cells expressing both GFP and BrdU were also quantified.  
Statistical Analyses: Statistical analyses were performed using the Prism 
GraphPad software. For direct comparison of two groups, Student’s t test was 
used. For comparison of multiple groups, one-way or two-way analysis of 
variance tests (ANOVA) were used with Bonferroni post-testing. Data are 
expressed as mean + standard error of the mean (SEM) unless otherwise noted. 
Significant differences between groups are marked on the graph with “*” denoting 
p value<0.05, “**” denoting p value<0.01, and “***” denoting p value<0.0001. 
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Scheme 2: Bone marrow transplantation protocol. Bone marrow was isolated 
from both hind limbs of 8 week old, male EGFP donor mice. These cells were 
harvested in sterile isolation medium, washed, filtered and reconstituted in sterile 
PBS for transplantation. Anesthetized animals were then given bone marrow 
cells via retro-orbital injection. Mice were closely monitored for 10 days to ensure 
recovery from the transplant. During this time, mice were fed normal chow and 
given water, by way of water bottles, ad libitum. Five weeks post-transplantation, 
mice were fed a 10% low fat or 60% high fat diet for the duration of the study. 
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Results  
Adiposity is significantly increased after 12 weeks of high fat diet. Because 
12 weeks of HFD has been suggested to promote maximal adipocyte 
hypertrophy and result in metabolic changes that promote a pre-diabetic state 
(15, 54, 56), this model was used to elucidate the impact of obesity on adipose 
stem cells.  For this, WT, C57BL6/J mice were fed either a 10% LFD or 60% 
HFD ad libitum for 12 weeks. Total body mass and total weight gain were 
significantly increased with consumption of HFD (Figure 11A,B). After 12 weeks 
of feeding, body composition was measured using Dexascan (Figure 11C,D). 
Dexascan analysis showed 12 weeks of HFD increased total body mass by 1.7-
fold (Figure 11E). Lean mass, which accounts for muscle and bone mass, was 
unchanged (Figure 11F). However, total fat mass increased 2-fold (Figure 11G) 
and fat mass as a percentage of the total body mass increased 3.5-fold (Figure 
11H) after 12 weeks of HFD.  
Consumption of high fat diet decreases activity. To examine the impact of 
obesity on metabolic and physiological activity, we placed obese and lean mice 
in metabolic cages for 24 hours. Beams along the bottom of the cage were used 
to determine the type, fine or ambulatory, and duration of movement. Each beam 
break was counted and the total number of beam breaks per 10 min interval was 
recorded and quantified (Figure 12).  Twelve weeks of HFD decreased total 
movements 1.9-fold (Figure 12 A,B).  Ambulatory movement counts were 
diminished 2.1-fold with HFD (Figure 12 C,D) and fine movements declined 1.5-
fold (Figure 12 E,F).  Respiratory exchange ratio was also decreased 
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significantly, 0.9009 ± 0.003135 with LFD and 0.7712 ± 0.001059 with HFD 
(Figure 12 G,H).   
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Figure 11. Adiposity increases significantly after consumption of a 60% fat 
diet for 12 weeks. Total body weight gain, (A), and delta body weight gain (B), 
are plotted in grams. Representative photographs and Dexascan images of mice 
fed a 10% low fat or 60% high fat diet for 12 weeks are provided above, (C) and 
(D), respectively. Total body mass, (E), lean mass, (F), and fat mass, (G), were 
quantified and presented in grams of tissue. Total fat mass is expressed as a 
percentage of the total body mass, (H); n = 4-6 per group; *p<0.05, **p<0.01, and 
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Figure 12: Consumption of high fat diet decreases activity. Male WT 
C57BL/6J mice were fed a low fat diet (LFD, 10% kcal fat) or high fat diet (HFD, 
60% kcal fat) for 12 weeks and the following measurements were recorded and 
means were quantified: Total activity level, (A) and (B); ambulatory counts, (C) 
and (D); fine movements, (E) and (F); and respiratory exchange ratio (RER), (G) 
and (H). n = 6 per group; ***p<0.001 vs. LFD. 
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Whole body glucose tolerance is significantly reduced by long-term 
consumption of a 60% high fat diet for 12 weeks. Mice fed a HFD had 
elevated blood glucose levels following a glucose challenge and area under the 
curve was increased 1.6-fold above LFD group (Figure 13A,B). There was not a 
significant difference in insulin tolerance (Figure 13D). Together, these data 
suggest that glucose tolerance is impaired due to diet-induced obesity.  
Visceral adipose depot expands tremendously with 12 weeks of high fat 
feeding. To examine gross changes in size, wet tissue wets of several organs 
were measured after the establishment of obesity. In this case, both epididymal 
fat pads were harvested and weighed together to yield a total visceral adipose 
tissue measurement, vWAT. There was a marked, 5-fold increase in the mass of 
the visceral adipose tissue of the mice fed a HFD (Figure 14). Since the visceral 
white adipose tissue was most significantly changed with obesity, we next 
assessed changes in the cell composition of visceral adipose tissue.  
Total T cell and macrophage populations increase significantly in visceral 
adipose tissue with obesity. To examine the inflammatory status of the adipose 
tissue, F4/80 positive cells (macrophages) and CD3 positive cells (T cells) were 
examined in the stromal vascular fraction isolated from the visceral and 
subcutaneous adipose tissue. Only the visceral adipose tissue showed significant 
differences in the total number of inflammatory cells per gram tissue due to high 
fat feeding, furthering support for the argument that the visceral adipose tissue is 
most significantly affected by the development of diet-induced obesity in our 
model. There was a 2.9-fold increase in F4/80 positive macrophage cells and a 
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1.9-fold increase in CD3 positive T cells in the visceral adipose tissue after 12 
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Figure 13. Measurements of insulin sensitivity in WT mice after 12 weeks of 
high fat diet.  After 12 weeks of a LFD or HFD, a glucose tolerance test, (A), and 
insulin tolerance test, (C), was performed on a cohort of obese mice. Area under 
the curve for the glucose tolerance test was calculated and expressed as such in 
graph (B). Area under the curve was calculated and normalized to the baseline 
glucose measurement for the insulin tolerance test, graph (D). For each 
measurement, n = 4 per group; ***p<0.001 vs. LFD. 
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Figure 14. Wet tissue weight of organs harvested from animals fed LFD or 
HFD for 12 weeks. After 12 weeks of feeding, tissues were collected from each 
of the mice and the wet weights are quantified above (A); n=6 per group; 
***p<0.001 vs. LFD. 
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Figure 15. Quantification of F4/80+ and CD3+ cell populations in visceral 
and subcutaneous adipose tissue after consumption of 60% high fat diet 
for 12 weeks.  The quantification for the total number of F4/80+ macrophage 
cells per gram of visceral or subcutaneous adipose tissue are presented above; 
graphs (A) and (B), respectively.  Quantification of the total CD3+ T cells per 
gram of visceral or subcutaneous adipose tissue is also included in the figure; (C) 
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Imbalance in progenitor cells pools in the visceral adipose tissue of obese 
mice. Adipocyte progenitor cells, APCs, and endothelial progenitor cells, EPCs, 
were identified as outlined in Scheme 3. To understand the diet-induced changes 
in these two populations, APCs and EPCs were identified in the stromal vascular 
fraction, SVF, using flow cytometry. Each SVF sample was stained with 
antibodies to detect cell surface antigens of interest. Based upon the expression 
of these antigens, the CD14- CD45- CD24+ CD29+ APCs and CD14- CD45- 
Sca-1+ Flk1+ EPCs were identified and quantified (Figure 16A,B). Though there 
was no significant difference in the number cells per gram fat with HFD, the ratio 
of APCs to EPCs was increased more than 5-fold in the high fat fed group 
(Figure 16C).  
Adipocyte progenitor cells in visceral adipose tissue of obese mice are 
bone marrow-derived. To determine the origin of the progenitor cell populations 
of interest, a bone marrow transplant was performed. Recipient mice were 
treated with a lethal dose of irradiation to eradicate all existing bone marrow 
cells. These cells were repopulated with GFP positive donor cells 24 hours after 
irradiation. To allow for proper repopulation, mice were monitored and 
maintained on normal chow for 5 weeks before they were placed on a low fat or 
high fat diet or 12 weeks. Bone marrow-derived, GFP positive APCs accounted 
for >96% of all APCs identified in the visceral stromal vascular fraction of both 
low fat and high fat fed mice (Figure 17B,C).  Conversely, >80% of EPCs were 
GFP negative, indicating that most EPCs in the visceral adipose tissue stromal 
vascular fraction derive from a tissue-resident pool (Figure 17E,F).  
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Proliferation of adipose tissue stromal cells is decreased after 12 weeks of 
HFD. BrdU was detected via histological analysis of paraffin-embedded visceral 
adipose tissue sections. The percentage of total DAPI positive cells expressing 
BrdU was decreased 1.48-fold HF-fed mice compared to mice fed LFD (Figure 
18A). BrdU positivity of bone marrow-derived cells expressing GFP was not 
different between the groups (Figure 18B).  These data suggest that proliferation 
of adipose tissue-resident stromal cells, whereas proliferation of bone-marrow 
derived cells is unaffected, by HFD.   
Reversion from 60% HFD to 10% LFD decreases adiposity and restores 
insulin sensitivity. We established a model of obesity by feeding 8 week old 
C57BL6/J mice a 60% HFD for 12 weeks and then reverted the animals to a 10% 
LFD for 4 weeks to determine if weight loss improved insulin sensitivity in mice. 
The reverted cohort experienced a significant amount of weight loss and after 4 
weeks of LFD, the percent weight gain measured in the reverted cohort was no 
longer different from that of the cohort fed a LFD for the entire 16 week period 
(Figure 19A). Area under the curve for the glucose and insulin tolerance tests 
was decreased significantly after reversion to LFD and was not significantly 
different from the LFD group (Figure 19D,E).  
Progenitor pools are increased after reversion of obese mice to a 10% low 
fat diet. Adipocyte progenitor cells, APCs, and endothelial progenitor cells, 
EPCs, were identified as previously described. To examine changes in the 
progenitor cell populations with weight loss, obese, HFD group was compared to 
the reverted, HFD-LFD, group. The weight loss induced a 7.7-fold increase in 
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APCs and a 4.4-fold increase in EPCs (Figure 20A,B).  The ratio of APCs to 
EPCs was also increased 1.5-fold (Figure 20C) compared to the HFD fed mice.  
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Scheme 3. Progenitor cell identification.  The diagram above depicts the 
method used to discriminate progenitor cell populations from the heterogeneous 
stromal vascular fraction. The same hierarchy is used to identify progenitors in 
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Figure 16. Quantification of adipocyte progenitor cell, APC, and endothelial 
progenitor cell, EPC, populations of visceral adipose tissue after 
consumption of 60% high fat diet for 12 weeks.  The quantification for the 
total number of CD14- CD45- Sca-1+ CD24+ CD29+ APCs per gram of visceral 
adipose tissue are presented above in graph (A).  Quantification of the total 
CD14- CD45- Sca-1+ Flk-1+ EPCs per gram of visceral adipose tissue is also 
included in graph (B). The ratio of APCs to EPCs is presented in graph (C); n=6 
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Figure 17. Quantification of adipocyte progenitor cell, APCs, and 
endothelial progenitor cell, EPC, populations of visceral adipose tissue 
after bone marrow repopulation and consumption of 60% high fat diet for 
12 weeks. After bone marrow transplantation with GFP+ stromal cells, mice were 
placed on 10% LFD or 60% HFD for 12 weeks. The quantification for the total 
number of CD14- CD45- Sca-1+ CD24+ CD29+ APCs per gram of visceral 
adipose tissue are presented above in graph (A). GFP+ and GFP- APC 
populations of in the LF, (B), and HF (C), cohorts are quantified as cells per gram 
tissue. Total CD14- CD45- Sca-1+ Flk-1+ EPCs in the visceral adipose tissue of 
bone marrow transplanted animals is presented as cells per gram tissue, (D). 
GFP+ and GFP- EPC populations of in the LF, (E), and HF (F), cohorts are 
quantified as cells per gram tissue. APCs to EPCs ratio is provided in graph (G); 
n=7-8 per group; *p<0.05, **p<0.01, and ***p<0.001 vs. LFD. 
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Figure 18. Quantification of BrdU in adipose tissue after 12 weeks of LFD or 
HFD. Quantification of the total percentage of BrdU+ cells are presented in graph 
(A). GFP+ BrdU+ cells in the visceral adipose tissue are also presented as a 
percentage of the total Dapi+ cell population (B); n= 4 mice/group (4-5 
images/animal) for LFD and n=4 mice/group (5-10 images/animal) for HFD; 
*p<0.05 vs. LFD. 
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Figure 19. Changes in adiposity, glucose tolerance, and insulin tolerance 
after reversion to 10% LFD. Weekly weight gain was quantified and presented 
as percentage of the initial body weight, (A). Blood glucose levels after 6 and 16 
hour fast can be found in graph (B). Changes in blood glucose level during a 
glucose tolerance test is presented in mg/dL, (C), and the area under the curve is 
quantified to the right, (D). Insulin induced changes in blood glucose level are 
plotted in (E) and quantification of area under the curve is presented in graph (F); 
n=8-18 per group; *p<0.05, **p<0.01, and ***p<0.001. 
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Figure 20. Quantification of adipocyte progenitor cell, APC, and endothelial 
progenitor cell, EPC, populations of visceral adipose tissue after 
consumption of 60% high fat diet for 12 weeks and reversion to 10% LFD 
for 4 weeks. The quantification for the total number of CD29+ APCs per gram of 
visceral adipose tissue are presented above in graph (A).  Quantification of the 
total number of Sca-1+ Flk-1+ EPCs per gram of visceral adipose tissue is also 
included in graph (B). The ratio of APCs to EPCs is presented in graph (C); n=9-
10 per group, *p<0.05, **p<0.01, and ***p<0.001 vs. HFD. 
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Discussion 
The major findings of this study reveal that progenitor cell balance may be 
essential to promote protective adipose tissue remodeling and that adipocyte 
progenitors are recruited from the bone marrow under conditions of nutrient 
excess. Our data show that 12 weeks of 60% HFD is sufficient to induce an 
obese phenotype in wild-type mice. Mice fed HFD exhibited impaired glucose 
tolerance, decreased physical activity, and increased body fat mass, primarily 
due to expansion of the visceral adipose tissue depot. This increase in adiposity 
increased the ratio of APCs to EPCs by 5-fold. Lineage tracing experiments 
confirmed that putative APCs are derived from bone marrow and that Sca-1+ 
Flk1+ EPCs are primarily resident to the tissue. While it has been shown that 
APCs can differentiate into mature adipocytes in vivo, the significance of the 
proportion of adipogenic and angiogenic precursors necessary to promote 
protective adipose tissue remodeling has not be fully described (37, 66).  
Our data show a 2.9-fold increase in macrophages and 1.9-fold increase 
in T cells after 12 weeks of HFD, which is in accordance with numerous studies 
showing that obesity promotes a chronic state of inflammation (55-57, 167, 174). 
Adipose tissue hypoxia has also been described to occur with obesity and is 
implicated as a potential contributor to the development of insulin resistance (55-
59, 172). EPCs have the capacity to repair damaged endothelium and to create 
new blood vessels in vivo (68, 69, 71, 79-82). We did not see a significant 
change in EPC number after 12 weeks of HFD, but the increase in APC to EPC 
ratio could be indicative of a diet-induced change in the stem cell composition of 
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adipose tissue; one which might impact adipose tissue remodeling. It is important 
to note, more than 96% of Sca-1+ Flk1+ cells were GFP- in mice consuming 
HFD, suggesting bone marrow-derived EPCs are not likely recruited to the 
adipose tissue during obesity. Moreover, we find that HFD appears to decrease 
the proliferation of tissue-resident cells, suggesting that, these resident EPCs 
might have decreased proliferative capacity and contribute to pathological 
adipose tissue remodeling.  This is important because decreased levels of these 
pro-angiogenic cells have been implicated in the development of several chronic 
diseases including cardiovascular disease, due likely to a diminished capacity to 
repair damaged vasculature (73-78). Obesity along with exposure to other 
environmental factors, i.e. air pollution and cigarette smoke, have been shown to 
negatively affect EPC numbers and function (68, 69, 71, 72).  
The imbalance of APCs to EPCs is an interesting finding of this study. 
Protective adipose tissue remodeling is characterized by the presence of large 
numbers of small adipocytes, decreased adipose tissue inflammation, and 
maintenance of metabolic homeostasis (56, 62, 63). APCs have been shown to 
proliferate, differentiate, and take up esterified lipid, expanding the adipose tissue 
(37).  Our studies show that HFD increases these cells in visceral adipose tissue 
and that this increase may be due to increased recruitment from the bone 
marrow since >96% of APCs were GFP+. The tissue-resident origin of the 
unchanged Sca-1+ Flk1+ EPC population in visceral adipose tissue could 
provide insight into the preference for pathological remodeling under conditions 
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of nutrient excess. Correcting the imbalance of these two cell types could be 
important in the discovery of novel therapeutic treatments for obesity.   
Addressing the question of whether the ratio of APCs to EPCs is crucial in 
promoting protective adipose tissue remodeling in conditions of nutrient excess 
would require interventions to correct the imbalance of these two cell populations 
in adipose tissue. Increasing the EPC population by way of cell transplantation or 
stimulation of EPCs to mobilize from the bone marrow to visceral adipose tissue 
with HFD are two methods by which this could be addressed. However, we have 
observed that subjecting mice to repeated injections can prevent body weight 
gain (unpublished observations). Because the goal of these studies would be to 
examine the adipose tissue remodeling process, the decreased weight gain 
could skew results. To mobilize the bone marrow EPCs pharmacologically, it 
would be advantageous to select an agent with minimal interactions with other 
progenitor cell types so that the contribution of mobilized cells to the remodeling 
processes could be clearly discerned.  
  In summary, our work provides information about the origins of adipose 
tissue stem cells and the diet-induced changes in their relative abundance.  We 
find that 12 weeks of HFD substantially increases gross tissue mass and 
inflammation, which was associated with increases in the ratio of APCs to EPCs.  
We also find that APCs appear to derive from the bone marrow and that Flk+ 
Sca+ EPCs are primarily tissue-resident.  The observation that tissue-resident 
stromal cells had lower BrdU positivity suggests that this population of EPCs 
could have defective proliferative capacity during conditions of nutrient excess.  
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Overall, these findings support our hypothesis that obesity impairs adipose tissue 
remodeling by negatively affecting stem cells and lends insight into a possible 
mechanism, i.e., that obesity impairs proliferation of adipose tissue-resident 
EPCs, leading to a decreased capacity to provide vascular support to forming, 










CONTRIBUTION OF STEM CELLS TO ADIPOSE TISSUE REMODELING 
  
Introduction  
 Stem cells play an important role in tissue homeostasis and repair (16, 56, 
63, 70, 71, 175). Mesenchymal stem cells (MSCs) have been successfully 
isolated from multiple tissues including skeletal muscle, adipose tissue, and bone 
marrow (37, 66, 176-178). These cells have also been shown to be give rise to 
several cell types including skeletal muscle, heart, joint, bone, and adipose tissue 
(177, 179-181).  MSCs isolated from skeletal muscle are relatively easy to obtain 
via muscle biopsy. Satellite cells, progenitor cells which are known to give rise to 
myoblasts, are located in close proximity to myofibers and though many of these 
cells are committed to the myogenic lineage, these CD29 positive cells can also 
undergo chondrogenic, endothelial, and osteogenic differentiation (177, 180, 
181). Bone marrow-derived cells expressing early cardiac markers as well as 
Sca-1, CD34 and AC133 have been shown to migrate to the damaged 
myocardium post myocardial infarction and are believed to be involved in repair 
of myocardium (179). In adipose tissue, there is a vast pool of progenitor cells 
including adipocyte progenitors (APCs), which can differentiate into mature 
adipocytes, and endothelial progenitors (EPCs), which promote the formation of 
new blood vessels as well as provide support for existing vasculature. There is 
also evidence that these adipose tissue stem cells can impose paracrine effects, 
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stimulating the migration of endothelial cells to prevent neointimal formation and 
promote vascular repair (37, 52, 66, 169, 182, 183). Since stem cells play a role 
in several organ systems, the competency and levels of these cells could be 
crucial to their ability to provide adequate tissue support; however, both of these 
characteristics can be affected by several factors (52, 68, 69, 73, 75, 82, 168).  
In adipose tissue, increased levels of stem cells could be indicative of 
favorable adipose tissue remodeling. Increasing these cell populations may allow 
for massive expansion of adipose tissue in response to HFD, while maintaining 
metabolic homeostasis. This results in the development of a benign state of 
morbid obesity predicated by an increased number of small adipocytes and 
systemic insulin sensitivity. For example, increased levels of adiponectin, a 
hormone secreted by adipose tissue, stimulated adipocyte progenitors to 
differentiate. In so doing, lipid uptake and energy expenditure of white adipose 
tissue are increased (62, 63).  
In the obese condition, adipocytes can expand tremendously to 
accommodate the excess lipid load, and in some cases, adipocytes hypertrophy 
to 10,000 µm in diameter (184). Since oxygen has a limited diffusion capacity in 
which it can only supply cells within a close proximity to a functional capillary 
bed, such an increase in adipocyte area creates a hypoxic environment in obese 
adipose tissue (58, 185-187).  Hypoxic conditions have been shown to inhibit 
adipogenic differentiation of mesenchymal stem cells (MSCs) from bone marrow 
and adipose tissue (188-191). Hypoxia also has an effect on the endocrine 
function of adipose tissue, suppressing production of adiponectin by adipocytes 
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(185, 186, 192, 193). Adiponectin is a hormone which has been shown to support 
proliferation of adipocytes as well as decrease inflammation in adipose tissue 
and vasculature (194). Adipose tissue of obese, transgenic mice that 
overexpress adiponectin, have been shown to have an increased number of 
smaller adipocytes when compared to obese controls (63). Adiponectin also acts 
on endothelial cells to increase the production of nitric oxide (194), which is 
significantly decreased with obesity (109). Nitric oxide (NO) plays a role in a host 
of physiological processes including the regulation of blood flow, angiogenesis, 
and vasodilatation. In addition, NO and other reactive oxygen species have been 
shown to increase differentiation of preadipocytes or APCs in vitro (195-197). 
When preadipocytes were treated with an NO releasing agent, hydroxylamine, or 
a substrate of nitric oxide synthase, L-arginine, lipoprotein lipase and glycerol-3-
phosphate dehydrogenase were increased indicating adipogenic differentiation. 
Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase 
(eNOS) were both upregulated in differentiating cells, however differentiation was 
uninterrupted upon inhibition of iNOS suggesting that eNOS may have a more 
significant role in adipogenic differentiation of preadipocytes (197).  
Data from our previous study show no significant change in the number of 
adipocyte progenitor and endothelial progenitor cells after 12 weeks of high fat 
feeding. However, the ratio of the two cell populations is significantly increased 
with HFD. As previously described, both endothelial and adipocyte progenitor 
cells are necessary for the positive remodeling of the adipose tissue. Since 
obesity disrupts the balance of these two progenitor populations, we chose to 
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examine if correcting this imbalance might support a more metabolically 
favorable adipose tissue remodeling, improving diet-induced glucose intolerance 
and decreasing adiposity.  To do so, we increased the EPC population in adipose 
tissue of mice fed HFD by cell transplantation in an attempt to correct the APC to 
EPC ratio associated with HFD.  As an additional way of potentially improving 
vascular function, we also sought to determine if increasing expression of eNOS 
in bone marrow-derived cells would support favorable adipose tissue remodeling 
by increasing APC differentiation or increasing vascular perfusion.  
 To supplement EPCs in adipose tissue of obese mice, we performed a 
direct cell transplantation of bone marrow-derived EPCs isolated from wild-type 
or eNOS-Tg mice into visceral adipose tissue. After 12 weeks of 60% HFD, mice 
transplanted with eNOS-Tg bone marrow showed no difference in adipocyte size, 
glucose, or insulin tolerance when compared to WT transplanted group. 
However, there was an appreciable increase in adipose tissue vascularity of high 
fat-fed mice transplanted with eNOS-Tg bone marrow. Results from this study 
suggest that increasing the competency or number of progenitor cells may 
support angiogenesis in the obese condition.   
 
Experimental procedures  
Animal Studies and Procedures: All procedures were approved by the University 
of Louisville Institutional Animal Care and Use Committee. Four week old 
B6.SJL-Ptprca Pepcb/BoyJ (Pep Boy; wild-type; WT) mice were purchased from 
The Jackson Laboratory (Bar Harbor, ME). The mice were given several days to 
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acclimate to the animal facility before being subjected to a lethal dose of Ɣ-
radiation (950cGy) by way of a cesium source (173). Twenty-four hours after 
irradiation, bone marrow from 8 week old male eNOS-Tg and WT mice was 
isolated and used to transplant irradiated WT mice via a single retro-orbital 
injection. Approximately, 1×107 bone marrow stromal cells were injected into 
each mouse using 100µl sterile PBS as the vehicle. The WT mice were 
purchased from The Jackson Laboratory (Bar Harbor, ME) and the colony of 
eNOS-Tg mice was maintained at the University of Louisville. The transgenic 
mice were developed on a C57BL/6J background and the animals overexpress 
bovine eNOS due to manipulation of the preproendothelin-1 promoter. Five 
weeks after transplantation, at 9 weeks of age, bone marrow transplanted (BMT) 
mice were placed on either a 10% low fat diet (LFD; Research Diets, Inc., 
#D12450B) or a 60% high fat diet (HFD; Research Diets Inc., #D12492) for 12 
weeks. Water and diet were provided ad libitum and body weights were recorded 
each week. 
Cell isolation: Bone marrow stromal cells were isolated from the tibia and femur 
of both hind limbs of 8 week old GFP positive mice (The Jackson Laboratory, 
#006567). The cells were flushed from the bones using a sterile solution of PBS 
with 10% FBS and a 24G-needle and syringe and kept on ice until all cells had 
been isolated. Once the cells were isolated, the cell solution was underlayed with 
Fico/Lite-LymphoH (Atlanta Biologicals, I40150) in a 1:1 fashion in sterile conical 
tubes. The tubes were then centrifuged for 20 minutes at 1500G at 18⁰ C. The 
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interphase layer, or buffy coat, was carefully removed and the cells were washed 
twice.  
The stromal vascular fraction (SVF) was isolated from the visceral and 
subcutaneous adipose depots. The adipose tissue was finely minced and 
digested in collagenase (500CDU/mL PBS/HEPES) at 37⁰ C for 25 minutes. The 
mixture was then filtered to remove any particles larger than 100µm and washed 
several times to isolate the SVF cells for analysis. 
Cell culture: The isolated cells were cultured on Fibronectin-coated (Sigma-
Aldrich, F0895) 6 well dishes with 2mL of culture medium. The culture medium 
consists of EBM-2 basal medium (Lonza, CC-3156), EGM-2 SingleQuot Kit 
supplements and growth factors (Lonza, CC-4176), FBS (Atlanta biologicals, 
S11150H) and Penicillin-Streptomycin solution (Gibco, 15070-063). 48 hours 
after seeding the cells, the medium was refreshed. Medium was then changed 
every 24 hours for the next 3 days, then every 2 days until the cells were 
confluent.  
EPCs were removed from confluent 6 well plates using trypsin and 
neutralized with trypsin neutralization solution. This process usually takes some 
time because the cells tend to adhere tightly to the culture dish. 500µl trypsin was 
placed in each well for 5 minutes and then neutralized with 1mL of solution. This 
process was repeated 2 more times to remove the majority of the cells. The cells 
were the washed with PBS and centrifuged at 500G for 5 minutes to pellet the 
cells. 
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Endothelial Progenitor Cell transplantation: An aliquot of EPCs was used to 
calculate a total cell count, then aliquots of 1x107 cells were then placed into 
sterile Eppendorff tubes. The cells were then combined with Matrigel to bring the 
final volume to 500µl. The solution was injected into the epidiymal fat pads of 
obese mice at 6 injection sites, 3 per pad, using a 24G-needle and syringe. Mice 
were monitored for 10 days post cell transplantation.  
Body composition measurement: Lean mass, fat mass, percent body fat, and 
total body mass were measured by Dual X-ray Absorptiometry (DEXAscan) 
paired with a mouse densitometer (PIXImus; Lunar, Madison, WI). For this 
measurement, the body weight of each mouse was taken prior to the scan and 
animals were anesthetized with isofluorane gas for the duration of the 
DEXAscan. Measurements for each parameter were recorded and images of 
each animal were collected.  
Glucose and Insulin Tolerance Tests: After a 6 hour fast, a bolus of glucose 
(1.0mg/g in sterile saline) was injected i.p. and blood glucose measurements 
were taken over the course of 2 hours using blood collected from the tail vein. 
For insulin tolerance test, a bolus of insulin (1.5U/kg Humulin R in sterile saline) 
was injected i.p. into non-fasted mice and blood glucose was measured over a 2 
hour period.  
Adipocyte area measurement: Samples of adipose tissue were removed from the 
visceral and subcutaneous depots. The samples were fixed in 10% formalin, 
embedded in paraffin, sectioned, and stained with hematoxylin and eosin for 
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histological assessment. Adipocyte number and area were quantified using the 
Nikon Elements-Basic Research software package.   
Immunostaining of adipose tissue: Isolectin was used to assess capillary density 
in the adipose tissue sections as described in Sansbury, et al. Circ Res, 2012. 
Staining for transplanted cells, adipocytes, and cell nuclei were done using 
primary antibodies against the following proteins; GFP, perilipin, and dapi, 
respectively. Distinct fluorescent secondary antibodies were used to detect each 
of the primary antibodies. This was done in collaboration with the Pathology 
CORE of the Diabetes and Obesity Center at the University of Louisville.  
Imaging of adipose tissue: Images of the hematoxylin and eosin stained sections 
were taken using a Zeiss microscope from SPOT Imaging Solutions. The Zeiss 
confocal microscope belonging to the Department of Molecular Cardiology at the 
University of Louisville was used to generate images of the fluorescent-stained 
adipose tissue sections. The Carl Zeiss ZEN 2012- blue edition was used to 
capture and analyze each of the confocal images.  
Analysis of adipose tissue by flow cytometry: SVF cells were isolated as 
previously described in this chapter and used for flow cytometric analysis. The Fc 
receptor was blocked for 10 minutes at 4⁰ C to prevent non-specific antibody 
binding. The SVF cells were then stained for 30 minutes at 4⁰ C with antibodies 
to detect each of the following cell populations: adipocyte progenitor cells (Sca-1, 
CD24, CD29, CD90.2), endothelial progenitor cells (Sca-1, Flk1), and 
hematopoietic cells (Sca-1+ CD34+). All antibodies were (purchased from 
eBioscience or Biolegend) conjugated to unique fluorochromes for detection in 2 
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or more distinct panels. Samples were analyzed using the BD LSR II and 
FACSDiva Software. Experiment files were exported and further analyzed using 
the FlowJo analysis software.  
The WT mice that we used as recipients for the bone marrow transplant 
were “Pep Boy” mice ordered from The Jackson Laboratory. We chose to use 
these mice as recipients because they express the cell surface antigen CD45.1 
instead of CD45.2, unlike the C57BL6/J mice which are commonly used as our 
WT model. The homozygous eNOS-Tg mice express CD45.2 so by using these 
two strains, we were able to assess the efficacy of the eNOS-Tg bone marrow 
transplant by flow cytometric analysis using antibodies against CD45.1 and 
CD45.2 purchased from eBioscience.  
Statistical Analyses: Statistical analyses performed using the Prism GraphPad 
software. For direct comparison of two group, Student’s t test was used. For 
comparison of multiple groups, one-way and two-way analysis of variance tests 
(ANOVA) were used with Bonferroni post-testing. Data are expressed as mean + 
standard error of the mean unless otherwise noted. Significant differences 
between groups are marked on the graph with “*” denoting p value<0.05, “**” 
denoting p value<0.01, and “***” denoting p value<0.0001. 
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Results  
Adipocyte area is unchanged 10 days after direct cell transplantation. 
Hematoxylin and eosin staining of adipose tissue sections reveal an increase in 
interstitial cells in visceral adipose tissue of obese mice compared to the 
subcutaneous depot (Figure 21A).  Further histological analysis would need to be 
completed to determine the identity of these cells, however their presence might 
be indicative of adipose tissue remodeling during which inflammatory cells, stem 
cells, and extracellular matrix components are all significantly increased (56, 57, 
175).  Adipocyte area measurement shows no significant difference between 
vehicle-treated and EPC-transplanted animals in either the visceral (vehicle, 
6022 ± 330.6; EPC, 6345 ± 539.4) or subcutaneous (vehicle, 7435 ± 655.9; EPC, 
7402 ± 723.2) adipose tissue depots (Figure 21B,C).   
Transplanted cells engraft into capillaries of the visceral and subcutaneous 
adipose tissue within 10 days. After GFP+ EPC transplant, adipose tissue 
sections were fixed and stained to determine if integration of transplanted bone 
marrow cells occurred. Cells which are co-stained with isolectin and GFP 
represent transplanted bone marrow-derived cells which have integrated into the 
existing vascular network or formed a new blood vessel. As seen in Figure 22, 
several GFP positive cells in the visceral and subcutaneous adipose tissue of the 
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Figure 21. Hematoxylin and eosin stained paraffin-embedded visceral and 
subcutaneous adipose tissue sections. Visceral, vWAT, and subcutatneous, 
sWAT, adipose tissue sections from vehicle and EPC injected animals were 
stained for histological assessment, (A). These images were taken at 20× 
magnification. Average adipocyte area of cells in the visceral adipose tissue and 
subcutaneous adipose tissue is quantified in graphs (B) and (C), respectively; 
n=3 per group.  
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Figure 22. Representative confocal images of isolectin stained adipose 
tissue sections. Samples of visceral and subcutaneous adipose tissue were 
fixed in formalin, embedded in paraffin, sectioned, and stained to visualize GFP+ 
EPC integration into isolectin stained capillary networks. GFP negative and 
positive controls as well as representative images of subcutaneous and visceral 
adipose tissue from EPC-transplanted and vehicle-injected mice are presented, 
(A) and (B), respectively.  
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Transplantation of eNOS-Tg stromal cells increased total body mass after 12 
weeks of HFD. Total body weight and weekly weight gain were significantly 
increased with HFD in both mice transplanted with WT and eNOS-Tg bone 
marrow (Figure 23E-H). Dexascan analysis showed that total body mass was 
modestly increased (1.08-fold) in mice transplanted with eNOS-Tg bone marrow 
compared with mice transplanted with WT bone marrow after 12 weeks of HFD 
(Figure 23I). Percent body fat was increased 1.8-fold HFD in both the WT and 
eNOS-Tg transplanted groups (Figure 23J). Regardless of the diet, average lean 
mass was not different in mice transplanted with WT bone marrow; the lean 
mass of mice in the HF eNOS-Tg group was 1.1-fold higher than that of the LF 
eNOS-Tg group (Figure 23K). Fat mass increased 2.6-fold in eNOS-Tg 
transplanted animals and 2.4-fold in WT transplanted animals after 12 weeks of 
HFD (Figure 23L).  
Systemic insulin sensitivity was not changed with transplantation of eNOS-Tg 
bone marrow. Fasting blood glucose levels were elevated 1.3-fold in eNOS-Tg 
HFD group compared to eNOS-Tg LFD after a 6 h fast (Figure 24A). After a 16 h 
fast, glucose levels were 1.7-fold higher in HF WT compared with LF WT and 
1.4-fold higher in HF eNOS-Tg compared with LF eNOS-Tg (Figure 24A). 
Glucose and insulin tolerance tests showed a diet-dependent difference in area 
under the curve; however there was no significant difference between WT and 
eNOS-Tg transplanted groups (Figure 24D,G).  
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Figure 23. High fat diet increases adiposity in WT and eNOS-Tg bone 
marrow transplanted animals.  Representative pictographs and Dexascan 
images of each group are presented and labeled accordingly, (A), (B), (C), and 
(D). Total body weight, (E) and (G), and delta weight gain, (F) and (H), are 
expressed in grams. Dexascan parameters, including total body mass (I), lean 
mass (K), and fat mass (L), are plotted in grams of tissue. Body fat expressed as 
a percentage of the total body mass is also included, graph (J); n = 4 per group; 
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Figure 24. Measurements of insulin sensitivity in bone marrow transplanted 
animals after 12 weeks of high fat diet.  After 12 weeks of a LFD or HFD, 
fasting blood glucose levels were measured after a 6 and 16 hour fast, (A). A 
glucose tolerance test, (B) and (C), and insulin tolerance test, (E) and (F), was 
also administered. Area under the curve for the glucose tolerance test was 
calculated and expressed as such in graph (D). Area under the curve was 
calculated and normalized to the baseline glucose measurement for the insulin 
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High fat diet induces a progenitor cell imbalance in visceral adipose tissue.  
APCs were not significantly changed after 12 weeks of HFD (Figure 25A). EPCs 
were significantly decreased in all groups compared to LF WT (Figure 25B). APC 
to EPC ratio showed a significant increase in both high fat-fed groups compared 
to LF WT, 10.8-fold in HF eNOS-Tg and 10.2- fold in HF WT (Figure 25C). Since 
CD34 positive cells have been shown to promote the formation of vasculature in 
vivo (79, 169), changes in the CD34 positive cell population was also examined. 
Similar to the endothelial progenitor cell population, CD34 positive cells were 
decreased in high fat-fed groups, 3.4-fold in HF WT and 2.7-fold in HF eNOS-Tg 
(Figure 25D).  
Isolectin staining is increased in adipose tissue of mice transplanted with eNOS-
Tg bone marrow after 12 weeks of HFD. Isolectin staining in adipose tissue 
sections from LF-fed mice did not appear to be different between WT and eNOS-
Tg transplanted groups (Figure 26A,B). In high fat-fed groups, isolectin staining 
appeared to be significantly increased in adipose tissue of mice that received 
eNOS-Tg bone marrow compared to WT (Figure 26C,D). In HF eNOS-Tg 
adipose tissue sections, formation of large vascular networks are visualized by 
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Figure 25. Quantification of progenitor cell populations of the visceral 
adipose tissue. Adipocyte progenitor cell, (A), and endothelial progenitor cell, 
(B), populations are quantified as cells per gram tissue. The ratio of these two 
cells types is presented in graph (C). CD34+ hematopoietic stem cells were also 
quantified as cells per gram tissue, (D); n=9-10 mice/ group, *p<0.05 and 
***p<0.001 vs. LF WT. 
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Figure 26. Isolectin staining of visceral adipose tissue sections after 12 
weeks of LFD or HFD. Representative images of adipose tissue stained for 
isolectin, perilipin, and DAPI are presented in the figure; LF WT, LF eNOS-Tg, 
HF WT, and HF eNOS-Tg are represented by figures (A), (B), (C), and (D), 
respectively. White arrows mark isolectin positive cells.   
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Discussion 
Major findings of this study show that increased expression of eNOS by 
bone marrow cells promotes vascularization of adipose tissue under conditions of 
nutrient excess. We also observed an increase in vascularization of 
subcutaneous and visceral adipose tissue upon direct cell transplantation of bone 
marrow-derived EPCs. In association with insulin resistance and glucose 
intolerance occurring in mice fed HFD, we also observed a significant decrease 
in adipose tissue EPCs.  Since it has been shown that vascular dysfunction and 
decreased nitric oxide may precede insulin resistance (109), we decided to 
perform a bone marrow transplant experiments to determine if increasing NO in 
bone marrow cells would promote favorable adipose tissue remodeling in 
conditions of nutrient excess. This study revealed a significant increase in APC to 
EPC ratio in all groups compared to WT LFD, due to a marked decline in Sca-1+ 
Flk1+ EPCs after 12 weeks of HFD and unchanged APC population. This 
supports our previous work suggesting that the imbalance of progenitor cell 
populations in the adipose tissue is diet dependent. It is also important to note 
that CD34 positive cells, which have also been identified as an endothelial 
progenitor populations (75, 79, 169, 170, 198), were significantly decreased with 
HFD. Despite a marked increase in total body mass and a decreased number of 
EPCs, mice transplanted with eNOS-Tg bone marrow showed an apparent 
increase in vascularity of adipose tissue with HFD.  
As previously discussed, NO has been shown to regulate differentiation of 
adipocyte progenitors (79, 197, 199) and is significantly decreased with obesity 
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(109). Repopulation of bone marrow with cells from mice overexpressing eNOS 
was intended to increase NO bioavailability and promote the formation of more 
vascularized capillary networks in adipose tissue. Our results show that 
vascularity of adipose tissue is significantly increased in HF-fed mice after 
transplantation of eNOS-Tg bone marrow cells, providing support for our 
hypothesis. This suggests that increasing eNOS may encourage the 
differentiation of progenitor cells in the adipose tissue to differentiate towards an 
endothelial lineage with HFD. If progenitors in the adipose tissue are in fact 
differentiating, this may account for the observed decrease we see upon analysis 
of the SVF.  
Though there have been numerous studies examining the contribution of 
EPCs to angiogenesis (75, 79, 169) and APCs to adipogenesis (35, 37, 66), not 
much is has been reported about the significance of the ratio of adipocyte and 
endothelial progenitor cells in the context of adipose tissue remodeling. In this 
study, we examined how correcting the imbalance of these two cell populations 
in obese mice might impact adipose tissue remodeling. To counter the increase 
in bone marrow-derived APCs we observed in mice fed HFD, we increased the 
total EPC population in adipose tissue of obese mice by way of direct adipose 
tissue cell transplantation. The average adipocyte area was not changed, 
however engraftment of GFP positive donor cells into vasculature of 
subcutaneous and visceral adipose tissue was evident 10 days after injection of 
bone marrow-derived EPCs. Prior to injection, EPCs were cultured for several 
days under normoxic conditions. Exposure of bone marrow-derived stem cells to 
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normoxic conditions has been shown to encourage differentiation (41). Perhaps, 
this “priming” of the transplanted bone marrow cells, increased their capacity to 
differentiate and incorporate into the vasculature in vivo. 
Accurate identification of endothelial progenitor cells is a limitation which 
will hopefully be addressed by future studies in this field. Several different 
endothelial progenitor populations are currently being studied and collectively, 
these cells are referred to as “EPCs” because of the pro-angiogenic nature of the 
cell type (68, 69, 71, 78, 80, 168, 170, 200). In mice, Sca-1+ Flk1+ cells are 
considered to be EPCs (69, 71). However, this characterization may not include 
all pro-angiogenic progenitor populations. More precise identification of murine 
EPCs would be helpful in determining which specific progenitor populations are 
contributing to adipose tissue remodeling and may be beneficial in the discovery 
of interventions and therapies to treat obesity. 
 In summary, our work provides insight into the role that stem cells play in 
the vascularization of adipose tissue during obesity. Through our work we were 
able to show that an acute increase in bone marrow-derived progenitor cells in 
adipose tissue of obese mice results in the engraftment of donor cells into 
existing vasculature and new capillary networks. This could help correct the stem 
cell imbalance occurring in obesity or prime stem cells to differentiate. Our data 
also show that a long-term increase in eNOS, established by bone marrow 
transplantation, increases vascularity in adipose tissue of high fat-fed mice. 
Perhaps NO is important in the regulation of stem cells during conditions of 
nutrient excess.  
 








 The purpose of this dissertation was to understand better how adipose 
tissue remodels to accommodate excess nutrients during obesity.  The most 
common cause for the development of obesity is hyperphagia resulting in the 
consumption of an increased amount of calories from fat (13-15). With this in 
mind, we used a nutrient excess model of obesity and examined structural, 
metabolic and compositional changes that occur in white adipose tissue during 
the development of obesity.  
Evidence in the literature supports two forms of adipose tissue 
remodeling—a pathologic form, which appears to be the default during white 
adipose tissue expansion, and a protective form that allows for increased fat 
storage capacity and maintains systemic insulin sensitivity (15, 62, 63). 
Adipocyte hypertrophy, insulin resistance, adipose tissue inflammation, and 
hypoxia are known to be associated with pathological expansion. Protective 
remodeling is characterized by proliferation of adipocyte progenitors in lieu of 
adipocyte hypertrophy. This type of remodeling allows for the preservation of 
metabolic homeostasis and insulin sensitivity; yet, why protective adipose tissue 
remodeling is not the default expansion method in diet-induced obesity remains 
unclear. The studies presented in this manuscript were completed in an effort to 
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investigate the mechanisms by which nutrient excess affects the adipose organ.   
We hypothesize that obesity impairs stem cell-mediated adipose tissue 
remodeling.   
 Prior to assessing this hypothesis directly, we first characterized the 
metabolic changes that occur in adipose tissue during obesity.  This is important 
because metabolic changes and metabolites are now recognized as signaling 
mediators that regulate cell and tissue dynamics.  To observe global metabolic 
changes after consumption of HFD, we completed several whole body 
physiological assessments as well as metabolomic analysis of adipose tissue. As 
described in Chapter 2, 6 weeks of HFD was sufficient to cause a marked 
increase in body fat composition as measured by Dexascan and an overall 
decline in physical activity was confirmed by metabolic cage analysis revealing 
decreased ambulatory and fine movements in mice consuming HFD. An increase 
in adipocyte area paired with substantial fat mass accumulation compared to 
LFD led us to investigate the metabolic changes in visceral adipose tissue after 6 
and 12 weeks of HF-feeding.  
Consumption of HFD has been shown to decrease mitochondrial 
abundance in adipose tissue (47-49). Our data showed that relative 
mitochondrial abundance was not different in mice fed HFD for 6 weeks 
compared to LF-fed group, however citrate synthase activity was decreased 
more than 2 fold. This enzyme is anchored to the mitochondrial matrix and is 
used in the Citric Acid Cycle for the conversion of acetyl-coA to citrate. Our 
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results suggest that a decrease in citrate synthase activity may precede overt 
diminishment of mitochondria.  
Insulin sensitizing drugs such as thiazolidinediones (TZDs) like 
pioglitazone and rosiglitazone have been shown to blunt this loss of mitochondria 
and even increase mitochondrial function in adipose tissue of obese individuals 
(49, 102). Interestingly, the role of TZDs has been examined in the context of 
stem cell biology. There is disagreement in the field about whether TZDs mediate 
the recruitment of bone marrow-derived cells to adipose tissue with consumption 
of HFD. Pioglitazone has been shown to decrease adipose tissue inflammation 
and adipose tissue macrophage accumulation induced by HFD (201). It was 
reported that rosiglitazone treatment encouraged engraftment of bone marrow-
derived cells in adipose tissue. This engraftment of bone marrow derived cells 
could also be seen to a lesser degree after feeding mice HFD. Data provided in 
this study suggest that the engrafted cells were multilocular in morphology and 
did not express CD11b or CD45, inflammatory cell markers (202). The next year, 
these results were countered suggesting that bone marrow-derived cells do not 
differentiate into adipocytes in vivo. Results of this study show that bone marrow-
derived cells accumulate in the interstitial space between adipocytes with HFD. 
These cells expressed CD11b, F4/80, LYVE-1 and CD45 indicating that these 
cells are most likely inflammatory cells (203). The major difference between 
these studies was the treatment with rosiglitazone. Perhaps TZDs not only 
impact mitochondrial abundance in mature adipocytes, but also promote 
adipogenic differentiation of bone marrow derived cells.  
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Our studies revealed that high fat diet induces the recruitment of bone 
marrow-derived adipocyte progenitor cells to visceral adipose tissue after 12 
weeks of HFD in the absence of pharmacological interventions. Characterization 
of these cells revealed that the bone marrow-derived population was not 
homogeneous. Characterization of SVF isolated from visceral adipose tissue 
showed more than 96% of the total APC population was derived from the bone 
marrow and approximately 20% of EPCs were bone marrow derived. However, 
upon analysis of intact adipose tissue, we did not observe any mature adipocytes 
which formed from the differentiation of a bone marrow-derived APC. We did 
however observe the engraftment of bone marrow-derived EPCs into vasculature 
of adipose tissue. Perhaps the metabolic changes in the adipose in response to 
HFD suppress the capacity of APCs to differentiate in conditions of nutrient 
excess.  
 One of the most robust changes that we observed via metabolomic 
analysis of visceral white adipose tissue of HF-fed mice was an increase in 
succinate. Succinate is an intermediate in the Citric Acid Cycle. The conversion 
of succinate to fumarate is catalyzed by Complex II, succinate dehydrogenase. 
This complex is composed of 4 subunits and after consumption of HFD for 12 
weeks, the abundance of one component, succinate dehydrogenase B (SDHB), 
was significantly decreased. Succinate dehydrogenase has been shown to 
impact cell differentiation and proliferation. One such study showed mutations of 
the gene encoding for succinate dehydrogenase have been shown to be 
associated with normal citrate synthase levels, reduced oxygen consumption, 
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and increase in HIF1-α which together increase cell migration and proliferation 
(204). HIF1-α has been shown to increase with obesity (58, 205). Succinate has 
also been shown to bind Gpr91, a Gi-coupled GPCR that regulates adipocyte 
function, and activate it (206). Upon binding its receptor in white adipose tissue, 
succinate inhibits lipolysis in adipocytes in vitro. (145).  Perhaps the environment 
created by nutrient excess impacts the differentiation of bone marrow-derived 
APCs or the proliferation of tissue-resident EPCs.   
In our assessment of the composition of the SVF isolated from HF-fed 
mice, we did not observe statistically significant changes in the number of APCs 
and EPCs. However, their relative abundance was changed, i.e., the ratio of 
APCs to EPCs was increased more than 5-fold with HFD. Since both endothelial 
and adipocyte progenitors are necessary for adipose tissue to expand in a 
metabolically favorable manner, the imbalance of these cell types could be 
critical for favorable adipose tissue remodeling.   
As previously described, HFD is associated with a host of metabolic 
changes in adipose tissue which can lead to mitochondrial dysfunction. Since NO 
is a major regulator of mitochondrial biogenesis (207, 208)  which is decreased 
with obesity, we experimented with increasing NO bioavailability under conditions 
of nutrient excess in the hope of generating a more perfused vascular network in 
the adipose tissue of obese mice. Interestingly, we found that HFD leads to a 
slightly greater increase in body mass of eNOS-Tg mice compared with WT 
transplanted mice. However, this did not induce changes in glucose tolerance, 
insulin tolerance, or stem cell abundance in adipose tissue compared to WT 
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transplanted groups. Perhaps increasing NO via this route, i.e., via bone-marrow, 
is not advantageous to the adipose tissue remodeling process, or it is possible 
that conditions of HFD lead to eNOS uncoupling, which is in line with our 
previous findings (Sansbury Circ Res 2012).  With regard to the former, this may 
be expected, as most of the EPCs in adipose tissue are resident to the tissue. 
In chapter 4, we sought to determine the contribution of stem cells to 
adipose tissue remodeling. Since the ratio of APC to EPC was significantly 
increased with HFD, we chose to correct the imbalance of these cells via direct 
transplantation of EPCs into adipose tissue. This was specifically aimed to 
determine if supplementation of the deficient population could improve insulin 
and glucose handling. After just 10 days there was an observable increase in 
donor cell engraftment into capillary networks of the adipose tissue, indicating 
that the proportion of these progenitor cells may be important to the adipose 
remodeling process.  
Engraftment of transplanted stem cells is a major issue in the field (209-
213), and culture conditions between cell isolation and transplant could modify 
cell competency.  For example, exposure of bone marrow-derived stem cells to 
increased oxygen levels for 5 days has been shown to be sufficient to promote 
survival, growth, and cell migration when cells are reintroduced to hypoxia (214). 
Since bone marrow-derived EPCs were primed in a normoxic culture 
environment prior to injection, perhaps the cells were preconditioned to 
differentiate and contribute to vascular stability in vivo.    
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 In summary, these studies provide new and essential understanding for 
how conditions of obesity affect adipose tissue stem cells and adipose tissue 
remodeling. We find that diet-induced pathological adipose tissue remodeling is 
characterized by increased numbers of bone marrow-derived APCs and an 
increase in the APC to EPC ratio.  We also find that APCs are derived 
predominantly from the bone marrow, whereas EPCs appear to be primarily 
resident to adipose tissue.  Hence, metabolic changes occurring in the adipose 
organ during obesity could have a greater effect on tissue resident cells, such as 
EPCs.  In line with this finding, BrdU staining in tissue-resident stromal cells of 
high fat-fed animals was lower than that of low fat-fed counterparts, which may 
be indicative of impaired EPC competency.  Transplantation of EPCs directly into 
adipose tissue increased isolectin positivity, suggesting that they could increase 
vascular density, and this was augmented further when the EPCs overexpressed 
eNOS.  Collectively, these studies demonstrate that obesity-induced 
derangement of adipose tissue stem cells in white adipose tissue is a modifiable 
target to combat obesity and its associated co-morbidities.  Exciting prospects for 
future studies include addressing the potential metabolic underpinnings of 
obesity-related changes in adipose tissue stem cells and determining how 
restoration of stem cell competency affects obesity and its associated 
complications.   
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